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Abstract 
Introduction: Extremely low frequencies of electromagnetic radiation are omnipresent where 
humans reside. These electromagnetic radiations are in the form of electrical power lines, 
transformers, electric hardware, and many household devices, such as hairdryers, electrical blankets 
and devices used in medicine and industry. The biological effects of extremely low frequencies of 
electrometric fields (ELF-EMF) at the cellular level have been linked with mice blood and 
immunological parameters. An understanding of cellular biological effects of ELF-EMF, particularly in 
the long term, is still lacking. The aim of this study thus was to measure the effects of ELF-EMF on 
15 blood parameters in 4-week old healthy male mice (Mus musculus); of the BALB/c strain. Blood 
parameters included the number of erythrocytes, leucocytes and four lymphocyte cluster of 
differentiation markers, and other related parameters. The expected outcome of the study is to show 
that ELF-EMF has an effect on blood parameters of mice. The two research questions pertaining to 
this study were:  1. To what extent does one-week exposure to ELF-EMF influence blood parameters 
in the BALB/c N1H mouse strain? 2. To what extent does twelve-week exposure to ELF-EMF 
influence blood parameters in the BALB/c N1H mouse strain? 
Methods: Two ELF-EMF exposure regimes were applied; a short-term exposure of one week 
(Experimental Trial 1) and a longer-term exposure of 12 weeks (Experimental Trial 2). Besides the 
control treatment group, a one-hour, four hours and 24-hours exposure treatments were applied 
daily to 25 randomly selected mice in each treatment group, at a magnetic flux density of 5 µT.  The 
mice were housed in specially designed polypropylene mouse cages. At the end of the two trials, 
blood was collected from the orbital cavities of the mice for analyses.  
Results and discussion: In Experimental Trial 1, ELF-EMF did not have a significant (p > 0.05) 
effect on the red blood cell population and the related parameters haemoglobin concentration and 
haematocrit; as well as on the number of thrombocytes and total leucocytes. The different leucocyte 
cell types did, however, show significant changes (p < 0.0001). The number of granulocytes, 
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eosinophils and basophils, was elevated, but the number of neutrophils was suppressed. The T-
lymphocyte CD3, CD4 and CD8 populations demonstrated significant increases in number, 
particularly in the one-hour ELF-EMF exposure group (p < 0.001). The B-lymphocyte CD19 
populations, did not show any differences when compared to the control treatment group (p = 0.57). 
When analysing the results of Experimental Trial 2, it was found that the control treatment groups 
were, for the most, highly significantly different when compared to the short-term exposure 
experiment (p < 0.001). These data indicated that long-term confinement resulted in other 
physiological changes, irrespective of whether the animals were exposed to ELF-EMF or not. These 
changes could probably be attributed to subclinical stress conditions brought about by confinement 
and the age of the animals. The control treatment groups showed suppressed numbers of total 
leucocytes, lymphocytes, monocytes, neutrophils and basophils, while the eosinophils were 
significantly elevated when compared to the short-term experimental control groups. The control 
groups of the T-lymphocyte CD3, CD4 and CD8 populations were also elevated when compared to 
the short-term experiment. In Experimental Trial 2, no significant differences could be established 
between the control treatment groups and the ELF-EMF exposure groups in all the parameters. It 
appears as if ELF-EMF adaptation and subclinical stress conditions modified the numbers of the 
respective parameters to such an extent that the control treatment and exposure treatment groups 
presented with equivalent numbers, making it difficult to isolate the effect of ELF-EMF exposure. 
Although the control treatment and treatment groups of the different parameters did not differ from 
one another, it appeared as if the four-hour ELF-EMF exposure may have contributed to the 
elevation of the number of red blood cells, haemoglobin concentration and haematocrit. Similarly, 
the basophils were also elevated in the one-hour ELF-EMF exposure group. 
Conclusions: The unexpected results of this study revealed that many gaps still exist in the 
understanding of the underlying effects of ELF-EMF exposure on living tissue, particularly blood 
parameters. How the immune response is activated and the role of confinement of animals and its 
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effect on the results of experiments needs further investigation. Finally, how the effects of ELF-EMF 
exposure in mice relate to ELF-EMF exposure in humans, also requires further elucidation. 
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Introduction 
1.1 Introduction 
The role and effects of electromagnetic fields in the lives of living organisms have interested 
scientists for more than two centuries. A hundred years ago, Ernest Solvay (1838–1922), a Belgian 
chemist, noted that “The phenomenon of life can and should be explained by the action of only 
physical forces which govern the universe and that, among these forces, electricity plays a 
predominant role” (Bassett 1992). The recognition of electromagnetism; the unity of electric and 
magnetic phenomena, is largely due to the contributions of Hans Christian Ørsted and André-Marie 
Ampère in 1819–1820 (Manzetti and Johansson 2012).  
Humans are constantly exposed to a variety of sources of electromagnetic radiation. Natural sources 
of electromagnetic radiation include sunlight, cosmic rays, and terrestrial radiations. However, since 
early in the 20th century exposure to artificial sources of electromagnetic radiation has increased 
substantially (Calvente et al. 2010). These sources include power stations, radio, radar, television, 
computers, mobile phones, microwave ovens, and numerous devices used in medicine and industry.  
 
Extremely low frequencies of electromagnetic radiation are omnipresent where humans reside. 
These electromagnetic radiations are in the form of, for example, electrical power lines, 
transformers, alternators, electric hardware, equipment of arc- and resistance-soldering and many 
household devices, such as hairdryers, electrical blankets and ovens (Touitou et al. 2013; Redlarski 
et al. 2015). In many cases pollution by extremely low frequencies of electromagnetic radiation is 
much stronger than any natural sources of electromagnetic fields or radiation (Redlarski et al. 2015).  
© Central University of Technology, Free State
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Advances in electromagnetic radiating technologies have aroused concerns about the potential 
health risks associated with exposure (Calvente et al. 2010). There has been considerable concern 
about the potential effects associated with extremely low frequency electromagnetic fields (ELF-
EMF) on the health of human populations (Patruno et al. 2015). Many epidemiologic studies have 
shown an association between ELF-EMF and cancer (Touitou et al. 2013; Redlarski et al. 2015). 
One of the first scientific studies supporting the notion that ELF-EMF are harmful to humans was 
demonstrated by Nancy Wertheimer and Ed Leeper in 1979 (Manzetti and Johansson 2012). These 
authors were looking for possible causes for a number of childhood leukaemia cases in the Denver 
metropolitan area. The outcome of this study showed that children with leukaemia were more than 
twice as likely to have lived in homes near high current power lines, where the electromagnetic fields 
were stronger. Further studies in the United States of America showed a statistical correlation 
between the emergence of childhood leukaemia mortality (at age 2–4 years) in the 1930s and the 
spread of residential electrification (Manzetti and Johansson 2012). Several epidemiological studies 
have linked ELF-EMF with an increased risk of cancer, for instance childhood leukaemia, brain 
cancer, breast cancer, kidney cancer, cancer of the nervous system and lymphoma (Patruno et al. 
2015). Association of ELF-EMF with other diseases include cardiovascular diseases, depression, 
suicide, and neurodegenerative diseases such as Alzheimer’s disease and amyotrophic lateral 
sclerosis (Touitou et al. 2013; Patruno et al. 2015).  
 
The biological effects of ELF-EMF at the cellular level have been noted in numerous studies. 
Particularly, studies on mice have indicated a link between ELF-EMF blood and immunological 
parameters (Dasdag et al. 2002). However, despite the volume of studies available, an 
understanding of the biological effects at the cellular level is still lacking; particularly the effects of 
long-term exposures (Kavet et al. 2001; Foster 2003; Santini et al. 2009; Patruno et al. 2015).  
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Animal models are extensively used to provide insight into the mechanisms underlying many human 
diseases. Although larger species, such non-human primates, are more closely related to humans; 
working with these large animals is extremely expensive and is fraught with ethical concerns. Thus, 
are thus extensively used. Mouse models are suitable for medical testing because their genetic, 
biological and behaviour characteristics closely resemble those of humans, and many symptoms of 
human conditions can be replicated in mice.  To obtain insight into the effects of ELF-EMF on human 
blood parameters, a mouse model (BALB/c N1H mouse strain) was subjected to ELF-EMF exposure. 
Therefore, the aim of this study was to measure the effects of an ELF-EMF on blood parameters of 
mice (Mus musculus). Two exposure regimes were applied, namely, a short-term exposure of one 
week and a longer-term exposure of 12 weeks. The blood parameters that were measured included 
the number of erythrocyte, thrombocyte, as well as a number of and leucocyte parameters. Four 
cluster of differentiation antigens (CD) on lymphocytes were also enumerated in this study. The 
expected outcome of the study is to show that ELF-EMF has an effect on blood parameters of mice. 
The research questions pertaining to this study were: 
1. To what extent does one-week exposure to ELF-EMF influence blood parameters in the 
 BALB/c N1H mouse strain? 
2. To what extent does twelve-week exposure to ELF-EMF influence blood parameters in the 
 BALB/c N1H mouse strain? 
To answer these research questions, the following objectives were devised: 
I. To design and build a system in which mice can be exposed to different ELF-EMF treatment 
regimens; 
II. To apply different expose treatment regimens of ELF-EMF to different groups of mice for 
shorter and longer periods; 
© Central University of Technology, Free State
C h a p t e r  1 :  I n t r o d u c t i o n   P a g e  | 4 
 
III. To determine the effects of the different exposure treatment regimens of ELF-EMF on a 
number of blood parameters; and 
IV. To analyse the data and reach conclusions.  
1.2 Ethical consideration 
The Animal Ethics Committee of the University of the Free State, Bloemfontein, Free State, South 
Africa, granted ethical approval for this project (see the Appendix for the ethics approval letter). This 
research project was executed in the animal house of the University of the Free State. 
1.3 Layout of thesis 
This thesis is arranged into seven chapters. 
Chapter 1: Introduction 
In this chapter, the field of study is introduced, the research problem identified, and the aim and 
objectives stated. 
Chapter 2: Literature review 
In this chapter, existing literature discussing the effects of ELF-EMF on human and animals is 
reviewed. 
Chapter 3: Materials and methodology 
In this chapter, a detailed description of the two experimental trials conducted in this study is 
provided, including the different exposure treatment regimens. A description of the construction of 
the experimental laboratories, as well as the methods used to determine the effects of ELF-EMF on 
the different mice blood parameters are also described. 
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Chapter 4: Erythrocytes and thrombocytes 
In this chapter, the results of the effects of the different exposure treatment regimens of ELF-EMF on 
the mice erythrocyte parameters and thrombocytes are presented and discussed. 
Chapter 5: Leucocytes 
In this chapter, the results of the effects of the different exposure treatment regimens of ELF-EMF on 
the mice leucocyte parameters are presented and discussed. 
Chapter 6: Cluster of differentiation 
In this chapter, the results of the effects of the different exposure treatment regimens of ELF-EMF on 
the mice cluster of differentiation (CD) parameters are presented and discussed. 
Chapter 7: Discussion and conclusions 
In this concluding chapter, the key findings of this research project are discussed and conclusions 
presented. Potential future research is also recommended. 
Appendix: 
The appendix contains the ethical clearance letter from the Animal Ethics Committee of the 
University of the Free State, Bloemfontein, Free State, South Africa. 
References:  
The references in this document have been prepared using the reference manager Mendeley. 
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Literature Review 
2.1 Introduction 
Exposure to electromagnetic fields is not a new phenomenon. During the twentieth century, 
exposure to electromagnetic fields started to increase steadily, particularly because of the ever-
growing demand for electricity and ever-advancing technologies. Continuous changes in social 
behaviours have also created more and more artificial sources of electromagnetic fields. People 
have constantly been exposed to a complex mixture of weak electric and magnetic fields, arising 
from the generation and transmission of electricity by domestic appliances and industrial equipment. 
Electromagnetic fields influence the human body just as they influence any other material made up 
of charged particles. 
2.2 Electromagnetic spectrum  
2.2.1 History of the electromagnetic spectrum 
Historically, visible light was the first component of the electromagnetic spectrum to be studied. The 
ancient Greeks recognised that light travelled in straight lines and later described the properties of 
reflection and refraction. Properties of the electromagnetic spectrum beyond visible light started to 
emerge in the 19th century, when William Herschel (1738–1822) identified electromagnetic radiation 
with the discovery of infrared radiation (Herschel 1800). He also noticed the temperature differences 
between colours of the colour spectrum. Later, Johann Ritter (1776–1810) discovered ultraviolet 
radiation, which lay beyond visible violet light rays of the electromagnetic spectrum (de Andrade 
Martins 2012). Michael Faraday (1791–1867) noticed that light became polarised when it passed 
through a transparent object in a magnetic field. At this time in 1845, he was able to link 
electromagnetism to electromagnetic radiation (de Andrade Martins 2012). A few years later, James 
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Maxwell (1831–1879) developed four partial differential equations for the electromagnetic spectrum. 
Two of the equations predicted the presence and behaviour of waves in the spectrum. Maxwell 
realised that these waves travelled at the speed of light and concluded that light was a type of 
electromagnetic wave (Maystre 2014). He also predicted waves of very low frequencies when 
compared to infrared. This was the first indication of the existence of the entire electromagnetic 
spectrum. 
Later in the 19th century, radio waves and microwaves were described. The physicist Heinrich Hertz 
(1857–1894) built an apparatus that generated and detected radio waves. He also produced and 
measured microwaves (Maystre 2014). The discovery of radio waves and microwaves paved the 
way to the inventions of the wireless telegraph and the radio. 
Wilhelm Röntgen (1845–1929) discovered a new type of radiation in 1895 called x-rays. He noticed 
that x-rays were able to travel through parts of the human body (Vetter 2016). These discoveries 
lead to the modern day use of x-rays in medical diagnostics and therapeutic procedures.  
Early in the 20th century, Paul Villard (1860–1934) studied the radioactive emissions of radium. He 
described a type of radiation similar to known alpha and beta particles with a high level of 
penetration ability (Gerward and Rassat 2000). Later, William Henry Bragg (1862–1942) 
demonstrated that the alpha and beta particles described by Villard were electromagnetic radiation 
and not particles (del Regato 1981). Ernst Rutherford (1871–1937) named this type of radiation 
gamma rays in 1903 (del Regato 1981). 
2.2.2 Range of the electromagnetic spectrum 
The electromagnetic spectrum describes the range of all electromagnetic waves. Electromagnetic 
waves have both an electrical and a magnetic component (International Agency for Research on 
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Cancer 2002; Hawkes et al. 2014). Typically, electromagnetic waves can travel without a medium 
and thus makes it possible to see light from distant stars and planets because light can travel 
through the vacuum of space. At the one extreme of the electromagnetic spectrum are the waves 
with the lowest frequencies; while at the other extreme are the waves with the highest frequencies 
(IARC 2002; Hawkes et al. 2014).  
The electromagnetic spectrum has been divided into regions defining each of the different wave 
types. Although this division is accurate, in reality there is often some overlap between neighbouring 
types of electromagnetic waves. At the low frequency end of the spectrum are, for example, radio 
and microwaves, with extremely low frequency waves lying at the extreme end of the low frequency 
end (Scenihr 2007). At the high frequency end of the electromagnetic spectrum are gamma rays with 
the highest frequencies of all the electromagnetic waves (Genuis 2008). Although the extreme ends 
of the electromagnetic spectrum have been defined, it is understood that the electromagnetic 
spectrum is continuous (Hawkes et al. 2014). The limit for long wavelengths is the size of the 
universe itself, while it is thought that the short wavelength limit is in the vicinity of the Planck 
constant (1.616 x 10-35 m) (Hawkes et al. 2014). 
Electromagnetic waves are typically described by three physical properties. These properties are 
wavelength (λ), frequency (f) and photon energy (E) (Genuis 2008). Since all electromagnetic waves 
travel at the speed of light, the wavelength can be determined by dividing the speed of light by the 
wave's frequency (Table 2.1). Thus, wavelength is inversely proportional to the wave frequency. This 
means that as frequencies increase, the wavelengths decrease (Kostoff and Lau 2013). Photon 
energy is directly proportional to wave frequency. Extremely low frequency electromagnetic waves 
have low photon energies, while high frequency gamma rays have high photon energies (Genuis 
2008). 
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Table 2.1 Frequencies, wavelengths and applications of electromagnetic waves.  
Frequency zone Frequency Wavelength in air Examples of 
applications 
Author 
Extremely 
low 
< 300 Hz > 1000 km 
Many biological 
processes 
Scenihr (2007) 
Low, 
middle, 
high 
30 kHz–30 MHz 10 km–10 m 
Amateur radio, remote 
controls 
Hitchcock (2012) 
Very high, 
ultra-high 
30–300 MHz 10–1 m Radio and television 
Hitchcock (2012) 
Super high 300 MHz to 30 GHz 1 m–10 cm 
Satellite communication, 
GPS 
Hitchcock (2012) 
Extreme 
high 
30–300 GHz 10–1 cm RADAR 
Hitchcock (2012) 
Infrared 300 GHz to 400 THz 1 mm–750 nm Television remote Calvente et al. (2010) 
Visible light 400–790 THz 760–400 nm Phototherapy Calvente et al. (2010) 
Ultraviolet 3 PHz–30 PHz 400–10 nm 
Sterilisation in the 
medical field 
Hawkes et al. (2014) 
X-rays 30 EHz–300 PHz 1 nm–10 pm 
Airport security and 
medical diagnostic 
imaging 
Hawkes et al. (2014) 
Gamma 
rays 
300 EHz > 1 pm 
Medical diagnostic 
imaging 
Hawkes et al. (2014) 
 
Electromagnetic waves of the different parts of the electromagnetic spectrum interact in different 
ways with matter. Typically, if the wavelength of electromagnetic waves is of a similar size to that of 
a particular object, then it is possible to probe the object with that frequency of light (Hawkes et al. 
2014). Gamma rays, x-rays and ultraviolet rays are classified as ionising electromagnetic waves 
(Calvente et al. 2010). These electromagnetic waves can cause damage to the human body, for 
example, by breaking down deoxyribonucleic acid (DNA) and causing cell damage (Calvente et al. 
2010; Greinert et al. 2015). Ultra violet light also may cause skin cancer in humans and animals 
(Greinert et al. 2015). At the low frequency end of the electromagnetic spectrum, non-ionising waves 
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are found. These include visible light, microwaves, radio waves and, extremely low frequency 
electromagnetic waves (Nicolaou et al. 2011). 
2.3 Extremely low frequency electromagnetic waves 
Extremely low frequency electromagnetic waves are found at the low frequency end of the 
electromagnetic spectrum. Generally these waves fall in the category of frequencies < 300 Hz (Otto 
and von Mühlendahl 2007; Ortega-Garcia et al. 2009; Redlarski et al. 2015; Zhang et al. 2016) with 
wavelengths > 1,000 km (Kostoff and Lau 2013). These wave types surround all electrical wiring and 
appliances (Saunders 2003). Normally, the electric and magnetic fields occur together. So, when an 
electric current runs through an electrical wire or appliance an electromagnetic field is generated 
surrounding the wiring and appliance. Magnetic fields are not shielded by most common materials 
and easily pass through them (World Health Organisation 2007; Hawkes et al. 2014). However, 
when an appliance is switched off the magnetic field disappears and only the electric field remains 
(Saunders 2003; WHO 2007).Both the electric and magnetic fields weaken with increased distance 
from the source (Ortega-Garcia et al. 2009). 
The electric and magnetic fields are measured using a variety of measuring units. The strength of 
the electric field is dependent on the voltage difference between two points in a circuit (WHO 2007). 
This voltage difference is measured in volts per metre (V/m) (WHO 2007). The magnetic field 
surrounding an electric current produces a flow of magnetic energy around the electric current, 
referred to as magnetic flux. Magnetic flux is a measure of the strength of a magnetic field around an 
electric current, based on the total number of magnetic lines of force that pass through a specific 
area (Hawkes et al. 2014). On the other hand, the magnetic flux density is the amount of magnetic 
flux in a unit area perpendicular to the direction of magnetic flow. Magnetic flux density is measured 
in Tesla (T) (1T = 795 800 A/m, µT = 0.7958 A/m), or more commonly in millitesla (mT) or microtesla 
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(µT) (WHO 2007). In some countries another unit called the gauss, (G), is commonly used (10,000 
G = 1 T). The greater the current, the higher the strength of the magnetic flux density. 
Extremely low frequency electromagnetic fields (ELF-EMF) exist when current flows (Hawkes et al. 
2014). Typically, power lines and cables, residential wiring and electrical appliances produce these 
electromagnetic fields (Ahlbom et al. 2000). Most electric power operates at a frequency of 50 or 60 
cycles per second, or hertz (Hz) (Redlarski et al. 2015). Close to certain appliances, the magnetic 
field values can be a few hundred µT (Havas 2002). Underneath power lines, magnetic fields can be 
about 20 µT. However, average residential magnetic fields in homes are much lower; about 0.07 µT 
in Europe and 0.11 µT in North America (WHO 2007).  
In a residential setting, there are three major sources that produce ELF-EMF. These sources include 
the outdoor electrical distribution system consisting of either below or above ground wires and 
transformers, the indoor electrical distribution system, consisting of indoor wiring and grounding, as 
well as appliances (Havas 2004). Indoor electromagnetic exposure depends on the condition of the 
wiring and the specific room in a house. Electromagnetic exposure differs in rooms of a house with 
measurements ranging from 0.11 to 1.22 µT. A house with normal wiring does not usually exceed 
0.03 µT (Riley 1995). Faulty wiring may lead to fields of 0.2 to 3 µT, with high readings near the 
walls, ceilings and floors of a house (Riley 1995; Havas 2002). The appliances of greatest concern 
are those with high magnetic flux densities and long exposure times. Electric blankets generate 2 to 
4 µT and are in contact with the body for several hours each night. Hair dryers and electric shavers 
also generate high magnetic fields close the head (Havas 2004). 
Occupational exposure to ELF-EMF varies amongst industries. The highest exposures have been 
measured in the textile, utility, transportation and metallurgical industries (WHO 2007). Dressmakers 
and tailors using industrial sewing machines are exposed to some of the highest magnetic flux 
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densities; in the order of 3 µT (IARC 2002). The magnetic flux densities encountered by utility 
workers; such as linemen, electricians, cable splicers, as well as power plant and substation 
operators, range from 1 to 4 µT, while metal workers, welders and aluminium galvanisers are exposed 
to values in the order of 2 µT (IARC, 2002). Railway workers are exposed to magnetic flux densities of 
up to 4 µT (IARC 2002). In the telecommunications industry, exposure is to relatively low magnetic 
flux densities ranging from 0.35 to 0.43 µT. Similarly, office workers, who come in contact with 
computers and photocopiers, are also exposed to relatively low magnetic flux densities of less than 
0.17 µT (IARC 2002).  
2.4 Biological effects related to extremely low frequency 
 electromagnetic  waves 
Exposure to ELF-EMF has been implicated in various cellular and physiological effects in humans 
(Cui et al. 2014). All living cells comprise of molecules and atoms, which in turn comprise of 
electrons, neutrons and protons; giving cells their electrochemical nature (Genuis 2008). The 
homeostasis of cells, tissues and organs, rely on the ordered chemical and electrical activity of these 
molecules and atoms. Disturbances of these chemical and electrical activities in cells have the 
potential to disrupt cell functioning, metabolism and homeostasis by interfering with the normal 
physiology of required energy frequencies; leading to malfunction of organ systems, which may 
ultimately result in clinical illness (Genuis 2008).  
Cellular pathogenesis as a result of ELF-EMF exposure is not completely understood (Genuis 2008). 
There still remains little agreement about the exact biological effects of ELF-EMF exposure and the 
mechanism underlying these effects (Santini et al. 2009). Various hypotheses have been proposed 
for the aetiology of cellular pathogenesis as result of ELF-EMF, based on preliminary evidence. 
Previously, it was believed that the underlying mechanism of the aetiology involves thermal 
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alteration of cells and tissue heating. However, increasing evidence suggests that ELF-EMF 
exposure could induce cell stress and cause damage on various intracellular components and 
mechanisms at the non-thermal level (Miyakoshi 2006; Calvente et al. 2010), although these 
suggestions of possible non-thermal effects remain controversial (Calvente et al. 2010). 
Changes in protein synthesis following ELF-EMF exposure are similar to a cellular stress response 
(Blank 1995). The stress gene HSP70 has been implicated in the cellular pathogenesis as result of 
ELF-EMF exposure. When cells are exposed to ELF-EMF, the stress gene HSP70 is activated within 
minutes (Lin et al. 1997; Goodman and Blank 1998 Wei et al. 2016). The activation of this gene is 
accompanied by the binding of heat shock transcription factors to specific nucleotide sites in the 
promoter of the HSP70 gene. The HSP70 gene has two stimulus-specific domains that respond to 
two different physical stimuli. These stimuli are electromagnetic fields and increases in temperature 
(Lin et al. 1999). The DNA consensus sequences that respond to electromagnetic stimuli are 
nCTCTn (Lin et al. 1997; 1999). The existence of two different consensus sequences, pertaining to 
the two different stimulus-specific domains in the HSP70 gene, is indicative of molecular evidence of 
different pathways that respond to non-thermal and thermal stimuli (Blank 2012).  
Various authors have suggested a variety of biological responses to ELF-EMF. Some of these 
biological responses include the genotoxic effect of ELF-EMF that may influence DNA synthesis, 
DNA damage and RNA synthesis in many cell types (Conti et al. 1999; Mahrour et al. 2005; Genuis 
2008; Shen et al. 2016) Other cellular responses to ELF-EMF include, alterations in cell proliferation 
and the cell cycle; the hindering of cell migration and adhesion, and alterations in the immune 
system (Blank 1995; Mahrour et al. 2005). Another interesting hypothesis is that ELF-EMF interferes 
with chemical reactions involving free radical production (Wolf et al. 2005). The pleiotropic effects of 
free radicals are well known and range from cytotoxic to mutagenic responses depending on the 
dose intensity, the duration of exposure, and the type of cell or tissue.  
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It is generally stated that energy exerted by ELF-EMF is too weak to interact with DNA and break 
chemical bonds in DNA molecules (McCann et al. 1997; Simkó et al. 2001; Cho and Chung 2003; 
Miyakoshi 2006; Zhang et al. 2016). The main cause of the scepticism is the low amount of energy 
that can be transferred by ELF-EMF (Dominici et al. 2011; Patruno et al. 2015). However, Santini et 
al. (2009) demonstrated that ELF-EMF do cause DNA damage (Santini et al. 2009), which is also 
supported by Zhu et al. (2001), who reported that ELF-EMF might induce DNA damage in 
lymphocytes. A dose-dependent increase in DNA breaks was demonstrated in animal brain cells 
with double strand DNA breaks appearing at 0.25 mT. The mechanism of interaction with DNA is 
probably through direct reaction with DNA (Rao et al. 2002). Specific mRNA level measurements in 
response to ELF-EMF exposure have shown to increase the levels of histone H3 and p53 mRNA 
(Cantini et al. 1986), IGF-II (Fitzsimmons et al. 1992), histone H2B, v-myc (Goodman et al. 1989), c-
fos (Rao and Henderson 1996), and c-myc (Lin et al. 1996); supporting direct interaction with DNA 
(Rao et al. 2002).  
The ELF-EMF potentially changes electrical charges of ions and molecules in cells, which may lead 
to the modification of ionic structures of elements within cell membranes, thereby disturbing the 
influx and efflux of various elements including calcium ions (Genuis 2008; Golbach et al. 2016). 
Thus, most theories suggest that because cell membranes play an essential role in mediating signal 
transduction events, they are by virtue of their bioelectrical properties the site where ELF-EMF exert 
their primary effects (Conti et al. 1999; Dini and Abbro 2005; Wolf et al. 2005). ELF-EMF are non-
ionizing and are able to penetrate deeply into tissue (de Kleijn et al. 2011). It is thus plausible that 
ELF-EMF may affect membrane structure and permeability to small molecules (Wolf et al. 2005). It 
has been suggested that ELF-EMF influence ion- and membrane potential-dependent-processes, 
such as Ca2+ influx and efflux. These processes, which are responsible for the mediation of 
intracellular signalling (Conti et al. 1999; Wolf et al. 2005; de Kleijn et al. 2011), demonstrated an 
increase in Ca2+ concentration after ELF-EMF exposure. This increase in Ca2+ could be attributed to 
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over-expression of voltage-gated Ca2+ channels (VGCC). A number of studies have suggested that 
these VGCC maybe one of the direct targets of ELF-EMF (Pall 2013; Cui et al. 2014). Changes in 
VGCC may thus lead to changes in intracellular Ca2+ concentration (Morabito et al. 2010). An 
increase of intracellular Ca2+ concentration can lead to changes in the intra-cellular signalling 
mechanisms (Miyakoshi 2006; Pilla 2012; Pall 2013).  
Based on the multitude of pleiotropic biological effects observed after exposure to ELF-EMF, Simkó 
and Mattsson (2004) presented a hypothesis suggesting an initial cellular event after ELF-EMF 
exposure. They suggested that ELF-EMF exposure results in a general cellular activation by means 
of increasing levels of free radicals. These authors further stated that exposure to ELF-EMF can 
cause both acute and chronic effects that are mediated by an increase in free radical levels. Direct 
activation by short-term exposure to ELF-EMF could lead to phagocytosis and macrophage 
activation; and consequently, free radical production. ELF-EMF could also increase the lifetime of 
free radicals resulting in persistently elevated free radical concentrations, thereby increasing the 
possibility of DNA damage. Long-term ELF-EMF exposure leads to a chronically increased level of 
free radicals, subsequently causing an inhibition of the effects of the pineal gland hormone 
melatonin. These induced reactions thus could lead to a higher incidence of DNA damage and 
therefore, to an increased risk of tumour development. In a related hypothesis by de Kleijn et al. 
(2016) proposed that ELF-EMF exposure can affect the hypothalamic pituitary-adrenal axis 
activation in mice as a result will affect number and activation of leukocytes. 
2.5 Cancer related to extremely low frequency electromagnetic 
 waves 
Since the time that Wertheimer and Leeper (1979) published a report showing an increased risk of 
cancer mortality amongst children living near electrical wiring; many studies linking electromagnetic 
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fields to health effects have ensued. Although studies have linked ELF-EMF exposure with health 
effects, the debate is still continuing whether the levels of exposure in domestic settings could cause 
cancer, particularly childhood leukaemia (Angelillo and Villari 1999). Most epidemiologic studies 
have been concerned with childhood cancer, although linkages with other types of cancer have also 
been made.  
Over the past three decades, potential health effects of residential and occupational exposure to 
ELF-EMF have been extensively investigated in epidemiological studies (Kheifets et al. 2010a). 
Infants and children are considered to be more vulnerable to environmental exposure of 
electromagnetic fields than adults (Calvente et al. 2010). Infant and childhood exposure have been 
implicated in numerous diseases raising concerns about the increased use of mobile phones and 
other household appliances (Zhao et al. 2014). Although most research has focused on a potential 
association between residential exposure and childhood leukaemia; an increased risk for childhood 
brain cancer has also been shown (Mezei et al. 2008).  
2.5.1 Leukaemia  
Ager et al. (1965) were the first authors who linked childhood leukaemia with environmental factors. 
However, Wertheimer and Leeper (1979) linked childhood cancer with electromagnetic fields. An 
excess of electrical wiring configurations, suggestive of high current-flow, was noted in Colorado in 
1976 to1977 near the homes of children who developed cancer, as compared to the homes of 
control children. Wertheimer and Leeper (1979) found that children exposed to ELF-EMF had a 2-
fold risk of developing leukaemia, as opposed to children with lower exposures. Their findings were 
strongest for children who had spent their entire lives at the same address, and it appeared to be 
dose-related. 
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Leukaemia is the most common malignancy diagnosed in children under the age of 15 years 
(Ahlbom et al. 2000). Leukaemia is divided into acute and chronic types, and acute lymphocytic 
leukaemia (ALL). The majority of childhood leukaemia cases (80%) are of the ALL type; primarily in 
children of ages 1–4 years (Metayer et al. 2013). ALL is characterised by the presence of immature 
blast cells in the bone marrow, blood and other tissues (Zelig et al. 2011). ALL is therefore a disorder 
of the lymphopoietic stem and progenitor cells originating from the bone marrow, thymus and lymph 
nodes (Pyatt and Hays 2010).  
The hypothesised risk factors associated with ALL include infections, benzene exposure, vehicle 
exhaust emissions, allergies, non-ionizing radiation and exposure to electromagnetic fields (Pyatt 
and Hays 2010). It has been shown that only 5% of ALL aetiology can be attributed to genetic 
disorders, chemotherapeutic agents and ionizing radiation (Pyatt and Hays 2010). It has also been 
suggested that the initial etiological event occurs in utero (Ziegelberger et al. 2011). Ding and Bao 
(2013) proposed that gene-environmental interactions may play a role in the aetiology of this 
disease. Globally, the incidence of ALL is increasing, also exhibiting geographic and ethnic 
differences (Pyatt and Hays 2010). Increased incidences are favoured in the industrialised countries 
over developing countries (Calvente et al. 2010). For example, the occurrence of ALL in the 
developing country Nigeria is low, as opposed to Denmark, a developed country, showing a 30-fold 
increase (Pyatt and Hays 2010).  
Various meta-analyses have indicated an epidemiological association between residential exposure 
to magnetic fields and the risk of childhood leukaemia (Kheifets et al. 2010a; Schüz and Erdmann 
2016). Particularly, the overall risk of leukaemia increased in children exposed to magnetic fields > 
0.3 µT (Greenland and Sheppard 2000) and ≥ 0.4 µT (Zhao et al. 2014). Studies have also shown 
that the risk for childhood leukaemia increases in the proximity of electromagnetic power sources. 
For example, in England and Wales the relative risk (RR) was 1.68 at 200 m from high-voltage 
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power lines, while the RR reduced to 1.22 at a distance of 200–600 m (Draper et al. 2005). These 
results were supported by a study in northwest Iran where the risk increased for childhood 
leukaemia in areas < 500 m from a high-voltage power lines (Feizi and Arabi 2007). 
The risk for childhood leukaemia increases in children born from mothers exposed to 
electromagnetic fields during pregnancy. It was shown in a study between 1980 and 1993 in 
Quebec, Canada, that the risk of a child developing leukaemia increases when a pregnant mother 
was exposed to levels of electromagnetic fields ≥ 0.4 µT (Infante-Rivard and Deadman 2003). In 
another study, Feychting et al. (2000) showed that parents exposed to electromagnetic fields with 
levels ≥ 3 µT, the risk for leukaemia developing in their children increased, although the risk only 
reached significance in boys. 
The association between exposure to ELF-EMF and childhood leukaemia has led to the 
classification of magnetic fields by the International Agency for Research on Cancer (IARC) as a 
“possible human carcinogen” (Kheifets et al. 2006). This association is regarded as the critical effect 
in risk assessment. 
A number of large studies have also linked adult leukaemia with exposure to ELF-EMF. In a study of 
2.8 million unselected Danes the occupational exposure to ELF-EMF was followed up over a 17 year 
period; from 1970 to 1987 (Guenel et al. 1993). Each person was classified according to his or her 
industrial occupation as either being intermittently exposed or continuously exposed to ELF-EMF. An 
increased risk of leukaemia in some occupations working with electricity could be demonstrated. 
These occupations included electricians, welders and flame cutters, aluminium workers, power and 
telephone linemen, electrical engineers, electronic technicians, radio and telegraph operators, and 
power station operators. In a small case-control study in New Zealand, an almost 3-fold increase in 
the risk for leukaemia was shown amongst welders and flame cutters (Bethwaite et al. 2001; 
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Johansen et al. 2007). In a Dutch cancer incidence study 120,852 men and women aged 55–69 
years at time of enrolment in 1986, were followed up 17.3 years later (Koeman et al. 2014). An 
increased risk was indicated for acute myeloid leukaemia amongst men with occupational ELF-EMF 
exposure. 
2.5.2 Breast cancer 
In the developed and developing world, breast cancer has been ranked worldwide as the fifth cause 
of death amongst all cancers (Girgert et al. 2005; Ferlay et al. 2010). Since the middle of the last 
century, the incidence of cancer has risen by 1% in the United States of America (Caplan et al. 
2000). This rise cannot to be explained completely by the known risk factors. This has led to 
numerous studies investigating the possible contribution of exposure to ELF-EMF produced by 
electric power facilities and household appliances (Caplan et al. 2000). In the past two decades, 
many epidemiological studies have shown the existence of a relationship with an increased risk of 
adult breast cancer and exposure to ELF-EMF, although these contentions remain controversial 
(Ottini et al. 2010). In animal studies, animals with breast cancer have demonstrated more tumours 
and larger tumours when exposed to ELF-EMF (Ottini et al. 2010). 
Breast cancer is the most frequent non skin cancer in women worldwide (Althuis et al. 2005; Porter 
2009). Studies have shown that premenopausal woman exposed to residential ELF-EMF and ELF-
EMF emitted from power lines may have an increased risk of breast cancer (Kliukiene et al. 2004; 
Girgert et al. 2005; Chen et al. 2013). In two studies, premenopausal women exposed to 
environmental fields stronger than 0.2 µT, showed an increased risk of breast cancer (Wertheimer 
and Leeper 1982; Feychting and Ahlbom 1993). In device measurement-based studies, a slight 
increased risk was found only in premenopausal breast cancer (Zhang et al. 2016). However, the 
converse was shown in studies conducted in Finland and Taiwan, where no link could be 
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established between populations living approximately 100 to 500 m from power lines and any 
increased risk of breast cancer in woman (Verkasalo et al. 1996; Li et al. 1997). 
Melatonin is a central component in circadian rhythms and helps control the sleep and wake cycles 
of a person. It is a hormone secreted by the pineal gland in the brain. It has been reported that a 
reduced expression of melatonin could be involved in carcinogenesis and reproduction problems 
(Reiter 1998; Levallois et al. 2001; Manzetti and Johansson 2012). A study during 2001 showed that 
melatonin levels in women living near power lines were lower than melatonin levels in women living 
away from any power lines (Erren 2001). It has been hypothesised that ELF-EMF may increase the 
risk of breast cancer by reducing the production of melatonin (Stevens and Davis 1996; Forssén et 
al. 2005; Li et al. 2013; Proietti et al. 2013). Radio and television broadcasting transmitters have 
been shown to reduce melatonin metabolites in women living in close proximity of these ELF-EMF 
transmitters (Manzetti and Johansson 2012). For a decade, there has been evidence that human 
breast cancer cells grow faster if exposed to ELF-EMF, probably because of the reduced melatonin 
levels in the body (Hardell and Sage 2008). 
With the increased use of electric devises in the household, such as electric bed-warming blankets, 
many studies have been conducted to ascertain if a link existed between the ELF-EMF of electric 
bed-warming blankets and breast cancer in woman. Most of these studies could not find an 
association with the risk for breast cancer (Vena et al. 1991; 1994; Gammon et al. 1998; Laden et al. 
2000; Davis et al. 2002; Chen et al. 2013; Feychting 2013). Similar results were obtained for pre- 
and postmenopausal women and for women with oestrogen-receptor positive breast cancer (Laden 
et al. 2000; Forssén et al. 2005). 
Breast cancer in men is rare; however the incidence of male breast cancer has risen over the past 
few decades (Ottini et al. 2010; Sun et al. 2013). Epidemiologic studies have demonstrated an 
© Central University of Technology, Free State
C h a p t e r  2 :  L i t e r a t u r e  R e v i e w   P a g e  | 21 
 
association between ELF-EMF exposure and male breast cancer (Ottini et al. 2010; Sun et al. 2013). 
In contrast, some studies found no or a weak association between ELF-EMF and male breast cancer 
(Johansen and Olsen 1998; Floderus et al. 1999; Pollán et al. 2001; Nichols and Sorahan 2005). 
The major risk factor for male breast cancer is a positive family history, because currently little is 
known about other risk factors such as those involving hormones and the environment (Ottini et al. 
2010). 
2.5.3 Brain cancer 
The highest rates of brain cancer have been noted in the more developed areas of the globe. In 
Europe, Australia/New Zealand, and North America, the incidence of new cases each year is around 
7.5–14 cases per 100,000 of the population’s males and 4–11 new cases for females. In contrast, in 
the developing world, for example Africa and the Pacific islands, the incidence of brain cancer is the 
lowest (Genuis 2008; Filippini 2012). 
The association between brain cancer and ELF-EMF from residential and environmental emissions 
has been investigated in a number of studies. A meta-analysis of 48 studies published during 1993 
to 2007 reported a small positive association between occupational ELF-EMF and brain tumours 
(Kheifets et al. 2008; Turner et al. 2014). Contradicting outcomes have also been reported, where 
little or no association between ELF-EMF and brain cancer in adults could be established (Kheifets 
2001; Kheifets et al. 2010b). However, a meta-analysis of occupational studies indicated a slightly 
higher risk for electrical workers (Genuis 2008). Astrocytoma and meningioma were the most 
common types of brain cancer associated with ELF-EMF exposure (Thériault et al. 1994; Floderus et 
al. 1999; Havas 2004; Baldi et al. 2011). Studies of residential exposure to ELF-EMF and childhood 
brain tumours have also produced inconsistent results (Filippini 2012). Most recent studies provide 
little evidence of an association between childhood brain cancer and ELF-EMF (Kheifets 2001; 
Kheifets et al. 2010b). 
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2.6 Other health-related effects related to extremely low frequency 
 electromagnetic  waves 
2.6.1 Haematology and immunology  
All blood cells are derived from haematopoietic stem cells in the red bone marrow. Haemopoiesis is 
the process in which all blood cells are formed through progressive division and maturation of 
haematopoietic stem cells. Three blood cell lineages exist, namely, erythroid cells, lymphoid cells 
and myeloid cells (Marieb and Hoehn 2016). Erythroid cells are the oxygen carrying red blood cells, 
while the lymphoid cells are composed of T-lymphocytes and B-lymphocytes, which form the 
foundation of the immune system (VanPutte et al. 2016). Lymphocytes express different protein 
receptors on their cell surfaces (antigens), which are referred to as clusters of differentiation (CD). 
These CD antigens participate in immune reactions as receptors for cellular communication. Myeloid 
cells include the granulocytes, megakaryocytes and macrophages and are involved in innate 
immunity, adaptive immunity and blood clotting. The nonspecific mechanism that is activated 
immediately or within hours of an antigen's appearance in the body is referred to innate immunity; 
while the adaptive immune system, also known as the acquired immune system, is a highly 
specialised mechanism that eliminates or prevents pathogen growth (Marieb and Hoehn 2016). 
 
When men were exposed to ELF-EMF, blood profiles did not reveal significant differences when 
compared to control groups. An examination of the profiles of haemoglobin concentration, 
haematocrit, red blood cells, platelets, total leucocytes, monocytes, lymphocytes, eosinophils and 
neutrophils suggested that these magnetic fields do not have a cumulative effect on these blood 
factors (Selmaoui et al. 1996). Touitou et al. (2013) found similar results for profiles of red blood 
cells, haemoglobin concentration, haematocrit, platelets, mean platelet volume, total white blood 
cells, lymphocytes, monocytes, eosinophils, basophils and neutrophils. A study carried out on 16 
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male welders also could not establish significant effects of ELF-EMF on red blood cells, 
haemoglobin, haematocrit, platelets, total white blood, neutrophils, lymphocytes and eosinophils 
(Dasdag et al. 2002). 
In contrast to the human studies, some significant differences could be established for blood factors 
in mice. Exposure of mice bone marrow cells to ELF-EMF showed a reduction in the proliferation 
and differentiation of the granulocyte-macrophage progenitors when compared to non-exposed bone 
marrow cells (van den Heuvel et al. 2001). In another study, a significant decrease in the counts of 
monocytes, platelets, peripheral lymphocytes, as well as splenic total T- and B-lymphocytes levels 
were observed (Hashish et al. 2008). 
 
Various studies have been conducted to investigate the influence of ELF-EMF on immunological 
parameters. The vast majority of these studies could not identify an association between these 
magnetic fields and the immune system. Selmaoui et al. (1996) found no effects on the 
immunological parameters CD3, CD4, CD8, natural killer cells and B-lymphocytes in 16 healthy men 
aged 20–30 years. Similar results were found for 15 men exposed to ELF-EMF (Touitou et al. 2013). 
No cumulative effects could be established for CD3, CD4, CD8, natural killer cells, B-lymphocytes, 
total CD28, CD8+, CD28+ and activated T-lymphocytes. In a study carried out on 16 male welders, 
the results also suggested that ELF-EMF do not affect the immunologic parameters CD3, CD4, CD8 
and CD4/CD8 (Dasdag et al. 2002). Contrary to these studies, a few studies have suggested some 
effects on the immune system. When Bonhomme-Faivre et al. (1998a) monitored ELF-EMF 
exposure in hospital laboratory workers, they observed lowered CD3 and CD4 lymphocyte counts, 
but increased natural killer cell counts. The numbers of natural killer cells and oxidative bursts of 
monocytes, which are implicated in cytotoxic responses, were significantly increased in 10 men 
working with induction heaters, while monocytes had significantly reduced phagocytic activity 
compared with those from unexposed workers (Tuschl et al. 2000). These authors concluded that 
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overall the non-specific immunity of the exposed workers was normal and that the most peculiar 
finding was the increase in natural killer cells. A study of 60 workers of power utilities revealed that 
there was an association between exposure intensity and a decreased ornithine decarboxylase 
activity and lowered natural killer cell counts (Ichinose et al. 2004).  
It has been shown that ELF-EMF have an effect on components of the immune system in vivo by 
inducing changes in blood cell levels in both mice and rats. This effect was probably caused by 
lymphocyte proliferation (Hashish et al. 2008). It has also been suggested that ELF-EMF might 
influence macrophage functioning in vitro by increasing free radical production and stimulating 
phagocytic activity (Frahm et al. 2006; 2010). Thus, it has been concluded that ELF-EMF exposure 
may modulate the innate immune response to microorganisms in animal models (de Kleijn et al. 
2011). 
2.6.2 Endocrine system 
Amongst the many hormones secreted by the human body, the neuroendocrine hormone melatonin 
has been the focus of most of the ELF-EMF exposure studies. Melatonin is a tryptophan derivative 
produced mainly by the pineal gland near the third ventricle in the brain. Melatonin is involved with 
regulation of multiple physiological processes, which include sleep patterns, free radical metabolism, 
blood pressure control, nitric oxide physiology, lipid metabolism, immune system functioning and the 
activity of sex hormones (Miyakoshi 2006). The melatonin secretion is generally regarded as being 
particularly sensitive to electric, magnetic and electromagnetic field exposure (Lewczuk et al. 2014). 
Several studies have shown that ELF-EMF exposure results in the reduction of melatonin 
production. A study into the effect of ELF-EMF on melatonin production in new-borns kept in 
incubators for at least 48 hours revealed that the melatonin levels increased almost immediately 
after the babies were taken out from the incubators (Bellieni et al. 2012). This result highlights the 
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potential for ELF-EMF exposure to influence the production of melatonin. Melatonin levels dropped 
significantly in repairers of electronic equipment exposed to ELF-EMF when compared to the 
controls (El-Helaly and Abu-Hashem 2010; Singh and Kapoor 2014). A reduction in the urinary 
melatonin metabolite, 6-sulfatoxymelatonin, was demonstrated in electrical utility workers (Burch et 
al. 1998; 1999; 2000; Lewczuk et al. 2014). This change in melatonin metabolite concentrations was 
noted after the second day of the working week and the effect of the magnetic field exposure was 
the most prominent in subjects with low workplace light exposures. One hypothesis that has been 
put forward to explain the inhibitory effect of electromagnetic fields on melatonin production is that 
the radical scavenging effect of melatonin is attenuated. However, at present, this hypothesis has 
not been definitively confirmed (Miyakoshi 2006). 
 
It has been hypothesized that the risk of breast cancer increases when melatonin production is 
reduced (Li et al. 2013). The alteration of melatonin production could change the risk of breast 
cancer through its regulation of reproductive hormones by influencing the hypothalamic-pituitary-
gonadal axis. Decreased concentrations of circulating melatonin may result in increased secretions 
of gonadotrophins by the pituitary gland and increased levels of ovarian hormone production by the 
ovaries, which could ultimately increase the risk of breast cancer (Tamarkin et al. 1981). 
2.6.3 Nervous system  
Evidence has suggested that 4.6 million new neurodegenerative disease cases appear globally 
every year (Ferri et al. 2005). Alzheimer’s disease is regarded as the most common of the 
dementias, contributing to about 75% of all cases (Mattsson and Simkó 2012). Neurodegeneration is 
a progressive loss of structure and function of neurons (Cannon and Greenamyre 2011; Mattsson 
and Simkó 2012). Although genetic factors play a role in the development of various 
neurodegenerative diseases, evidence suggest that occupational and environmental factors also 
contribute to the development of these diseases (Johansen and Olsen 1998; Davanipour et al. 2007; 
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Cannon and Greenamyre 2011; Mattsson and Simkó 2012). Neurodegenerative diseases that have 
been associated with ELF-EMF exposure include Alzheimer disease, Parkinson disease and 
amyotrophic lateral sclerosis (Cannon and Greenamyre 2011; Yin et al. 2016). These diseases all 
involve the death of specific neurons, although their aetiology seems to be different (Savitz et al. 
1998a; 1998b; Say et al. 2016). 
Alzheimer disease is a progressive degenerative disorder resulting from the degeneration of neurons 
causing loss of memory and cognitive abilities, as well as behavioural changes (WHO 2007). Studies 
investigating a possible association between Alzheimer disease and ELF-EMF are limited. In a study 
conducted with 1,527 patients at the Californian Alzheimer's Disease Diagnostic and Treatment 
Centres, Davanipour et al. (2007) demonstrated an increased risk to Alzheimer disease resulting 
from elevated occupational exposure to ELF-EMF. In a systematic review and meta-analysis of 14 
different studies, evidence suggested an association between occupational exposure to ELF-EMF 
and Alzheimer disease (García et al. 2008). 
Parkinson disease is a degenerative disorder of the central nervous system mainly affecting the 
motor system and is characterised by motor dysfunction, tremor, muscular rigidity and slow 
imprecise movements (WHO 2007). Little is known about the influence of ELF-EMF and Parkinson 
disease. However, Noonan et al. (2002) reported that an association between occupational ELF-
EMF exposure and Parkinson’s disease after studying males in the state of Colorado for the years 
1987 to 1996.  
Researchers have since the late 1970s been interested in the chronic health effects of ELF-EMF on 
psychiatric disorders. Many contradicting results have been published about the incidence of suicide 
and depression and their association with ELF-EMF exposure (van Wijngaarden et al. 2000). 
However, a few studies did reveal a strong association between ELF-EMF and suicide and 
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depression. Van Wijngaarden et al. (2000) provided evidence for a strong association between 
occupational electromagnetic fields and suicide amongst male electric utility workers, while Dowson 
et al. (1988) found a strong association between depression amongst people who lived near power 
lines in England.  
2.6.4 Skeletal and muscular effects  
Studies have demonstrated a therapeutic effect on bone repair by applying ELF-EMF. Bassett and 
his colleagues (1965;1967;1974) were one of the first groups to show that bone repair was 
augmented by electromagnetic fields. Bassett et al. (1974) showed that bone formation took place in 
areas of negative charge, while bone remodelling occurred in zones of positive charge. Although a 
full understanding of the underlying mechanisms behind these beneficial effects of ELF-EMF on 
bone repair is unclear, some important breakthroughs have been made (Santini et al. 2009). 
Preclinical studies have shown that electric and electromagnetic fields regulate proteoglycan and 
collagen synthesis in models of endochondral ossification, and increase bone formation in vivo and 
in vitro (Aaron et al. 1989; 2004). ELF-EMF accelerate bone formation and healing, particularly 
osteotomies and spine fusions. In vitro studies have shown the pulsed EMF stimulate 
osteoprogenitor cells and osteoblasts to proliferate and differentiate (Dimitriou and Babis 2007; Pall 
2013). 
To investigate the effect of ELF-EMF on muscle cells, single cells were exposed to ELF-EMF. 
C2C12 cells were used as an in vitro model of the skeletal muscle phenotype (Morabito et al. 2010). 
Exposure of these cells to ELF-EMF revealed an induced reactive oxygen species production in 
myoblasts and myotubes. A concomitant decrease in mitochondrial membrane potential was 
demonstrated, which activated the cellular detoxification system, thereby increasing catalase and 
glutathione peroxidise activities. This resulted in the alteration of intracellular Ca2+ homeostasis, by 
increasing spontaneous activity of myotubes and enhancing cellular reactivity. 
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A study of the effects of ELF-EMF on rat myocardial cells revealed changes in the myocardium. 
ELF-EMF caused oxidative stress, apoptosis and morphologic damage in myocardium of adult rats 
(Kiray et al. 2013). These changes in the myocardium could be attributed to increased oxidative 
stress. 
2.6.5 Cardiovascular system 
Although most epidemiologic studies have shown no effect of ELF-EMF on cardiovascular changes 
(Kheifets et al. 2007; McNamee et al. 2009), a large study conducted by Savitz et al. (1999) revealed 
an opposing outcome. The mortality from cardiovascular disease in relation to occupational 
magnetic field exposure amongst a cohort of 138,903 male electric utility workers from five USA 
companies over the period 1950 to 1988 was examined. The data from this study suggested a 
possible association between occupational magnetic fields and arrhythmia-related heart disease.  
2.6.6 Reproduction and new-borns  
Foetal development depends on an array of complex physiological processes and interactions. An 
adverse outcome of a pregnancy results because of complex interactions between maternal, 
placental, foetal and environmental factors present during pregnancy (de Boo and Harding 2006). 
These interactions are poorly understood. It is known that endogenous electric fields play a role in 
normal embryo development, by for example, guiding cell orientation and migration. Developmental 
abnormalities may thus result from disruptions from these electric fields (Saunders and McCaig 
2005). Whether ELF-EMF exposure during pregnancy could have a similar effect is still unclear 
(Feychting 2005). Although uncertainty of the causal agent exists, an increased risk of miscarriage 
has been linked to environmental ELF-EMF exposure (Li et al. 2002; Auger et al. 2011; 2012). In a 
study amongst pregnant women within a large health maintenance organisation in San Francisco, an 
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increased risk for miscarriage was shown with increasing levels of maximum magnetic field 
exposure with a threshold around 16 mG (Li et al. 2002). 
ELF-EMF exposure during pregnancy can affect new-borns adversely. Residential exposure to ELF-
EMF from high voltage cables, overhead power lines, electricity substations or towers have been 
associated with reduced birth weight and may be associated with adverse birth outcomes or even 
miscarriages (de Vocht and Lee 2014). A study of 140,356 singleton live births in Northwest England 
from 2004 to 2008 suggested that living close to residential ELF-EMF sources reduced average birth 
weight, but not with statistically significant increased risks for other adverse perinatal outcomes (de 
Vocht and Lee 2014). New-borns exposed to incubator conditions also demonstrated increased 
heart rate variability (Bellieni et al. 2008). 
Exposure to ELF-EMF has also been linked to testicular development. A study amongst switchyard 
workers revealed an increase in the number of chromosomal aberrations and an increased tendency 
towards malformations amongst their children. Fathers employed in industries with a higher 
exposure to ELF-EMF than average also tend to have children with higher rates of brain and spinal 
cord tumours (Genuis 2008). In rats, exposure to ELF-EMF cause significant histopathological 
alterations, such as focal tubular atrophy, necrosis, and seminiferous epithelial erosion (Erpek et al. 
2007). In male rat offspring, a reduction in the count, diameter, area and volume of seminiferous 
tubules, and height of seminiferous epithelium along with Leydig cell count, was indicative of the 
harmful effects of ELF-EMF on testis development (Tenorio et al. 2011). 
2.7 Epidemiological studies 
All epidemiologic studies to date have been based on retrospective assessments of exposure to 
ELF-EMF. It is unlikely that researchers will ever perform prospective research; given the potential 
health outcomes of such studies (Ahlbom et al. 2001). A large number of retrospective epidemiologic 
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studies have been conducted over the years to ascertain if associations existed between exposure 
to ELF-EMF and specific health effects, such as cancer, cardiovascular diseases and 
neurodegenerative diseases. Many of these studies are meta-analyses combining several previous 
studies. Table 2.2 provides a summary of several large epidemiological studies investigating the 
possible association between ELF-EMF exposure and health effects. Because many epidemiologic 
studies have indicated that ELF-EMF affects human health in one way or another; studies to 
elucidate the effects of ELF-EMF at a molecular and cellular level will continue. In conclusion, 
because of the lack of experimental evidence of biological studies and the contradictory reported 
results of epidemiological studies, this research project was undertaken to elucidate the effect of 
ELF-EMF at the cellular biological level. 
 
. 
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Table 2.2 Summary of epidemiological studies. 
Exposure effect 
Period of study 
/ total number 
meta-analyses 
Study population  Outcome Reference 
Cancer risk 42 studies 
13,259 cases 
100,882 controls 
Exposure to ELF-EMF increases the risk for cancer, particularly for 
premenopausal breast cancer. 
Zhang et al. (2016) 
Childhood leukaemia 
9 Studies 
3,203 cases  
10,338 controls 
Exposure to ≥ 0.4 µT ELF-EMF increases the risk for childhood 
leukaemia.  
Ahlbom et al. (2000) 
1997–2013 
9 studies 
11,699 cases  
13,194 controls 
Positive association between exposure to ≥ 0.2 µT ELF-EMF and 
childhood leukaemia.  
Zhao et al. (2014) 
1988–1996 
1,842 cases  
3,099 controls 
Hypothesis that night-time increases risk for childhood leukaemia could 
not be supported. 
Schüz et al. (2007) 
1962–995 
29,081 cases  
9,700 controls 
Exposure to ELF-EMF increases the risk for childhood leukaemia for 
children living within 200 m of power lines. 
Draper et al. (2005) 
Adult leukaemia 
1982–1998 
22 studies 
Not divulged 
Association between field exposure to ELF-EMF and adult leukaemia 
was inconclusive. 
Wang et al. (2000) 
Breast cancer in 
women 
1990–2010 
23 studies 
 
74,975 cases 
249,281 controls 
Exposure to ELF-EMF increases the risk for female breast cancer, 
especially for premenopausal and oestrogen receptor positive females. 
Chen et al. (2013) 
1966–2000 
24 studies 
> 5 M cases  
> 5 M controls 
Exposure to ELF-EMF increases the risk for female breast cancer. Erren (2001) 
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Exposure effect 
Period of 
study/total 
number meta-
analyses 
Study population  Outcome Reference 
Breast cancer in men 
1966– 2000 
15 studies 
> 5 M cases 
> 5 M controls 
Exposure to ELF-EMF increases the risk for male breast cancer. Erren (2001) 
1991–2012 
18 studies 
7 case-control studies 
57 cases 
223 controls  
11 cohort studies  
299 cases  
total of 7,486,643 
Exposure to ELF-EMF increases the risk for male breast cancer. 
 
Sun et al. (2013) 
1970–1987 2.8 M cases Exposure to ELF-EMF increases the risk for male breast cancer. Guenel et al. (1993) 
Depression and 
suicide 
1950–1986 
138,905 cases   
5,348 controls 
Positive association between occupational exposure to ELF-EMF and 
suicide. 
van Wijngaarden et al. (2000) 
Brain cancer 2000–2004 
3,761 cases 
5,404 controls 
Positive association between exposure to ELF-EMF and glioma. Turner et al. (2014) 
Cardio-vascular effect 1950–1988 138,903 cases 
Positive association between exposure to ELF-EMF and arrhythmia-
related heart disease. 
Savitz et al. (1999) 
Reproductive effect 2004– 2008 
140,356  
singleton live births 
Positive association between close residential (≤50 m) exposure to ELF-
EMF and reduced birth. 
De Vocht and Lee (2014) 
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Materials and Methodology 
3.1 Introduction 
Exposure to ELF-EMF has been implicated in various cellular and physiological effects in humans 
(Cui et al. 2014). However, cellular pathogenesis as a result of ELF-EMF exposure is not completely 
understood (Genuis 2008). Thus, this project was undertaken to study the effects of ELF-EMF on a 
number of cellular parameters in mice (Mus musculus). The cellular parameters included the number 
of erythrocytes (red blood cells; RBC); number of thrombocytes (platelets; PLT) and the number of 
the different classes of leucocytes (white blood cells; WBC). Four immunophenotyping cluster of 
differentiation (CD) classes, as well as the haemoglobin concentration, haematocrit and mean 
corpuscular volume were also included.  
This study forms part of a larger study, which focused on the biological effects of extremely low 
frequency electromagnetic field (ELF-EMF) exposure in mice. This research project was conducted 
under the auspices of three collaborating parties; the Central University of Technology, Free State, 
from South Africa; the University of Wageningen from the Netherlands and the Engineering 
Company Immunent BV, also from the Netherlands. 
3.2 Experimental design 
In this project, two experimental trials were performed. In Experimental Trial 1, mice were exposed 
to ELF-EMF for one week, while in Experimental Trial 2; mice were exposed for a 12-week period 
(Figure 3.1). The magnetic flux density applied in both experimental trials was 5 µT. In each 
experimental trial, four ELF-EMF exposure treatment regimens were applied to groups of 25 
randomly selected mice. These treatment regimens were as follows:  
© Central University of Technology, Free State
C h a p t e r  3 :  M a t e r i a l s  a n d  M e t h o d s  P a g e  | 34 
 
 A non-exposure treatment (control treatment); 
 A daily 1-hour exposure treatment from 8:00 until 9:00;  
 A daily 4-hour exposure treatment from 8:00 until 12:00; and 
 A 24-hour continuous exposure treatment. 
 
 
 
0-H = 0-hour exposure; 1-H = 1-hour exposure; 4-H = 4-hour exposure; 24-H = 24-hour exposure 
Figure 3.1 Study design. 
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3.3 Experimental animals and treatment facilities 
3.3.1 Experimental animals 
The experimental mice used in this study were supplied by the Animal Unit of the School of Medicine 
in the Faculty of Health Sciences, at the University of the Free State, Bloemfontein, South Africa. 
The mice used in both experimental trials belonged to the BALB/c N1H strain. This mice strain is an 
inbred albino strain, specifically bred for the testing of a variety of blood parameters. Only 4-week old 
healthy males were exposed to the various ELF-EMF treatment regimens. 
3.3.2 Treatment rooms 
Both experimental trials were conducted at the Animal Unit of the School of Medicine in the Faculty 
of Health Sciences, at the University of the Free State. The experimental trials were conducted in 
two treatment rooms. These treatment rooms were isolated from all other activities in the Animal 
Unit. The one treatment room was used as the control treatment room; where mice were not 
exposed to ELF-EMF. This treatment regimen was referred to as the 0-hour control treatment or 
control. In the other treatment room all three ELF-EMF treatment regimens were applied to the mice; 
1-hour, 4-hour and 24-hour exposures. The two treatment rooms were positioned approximately 20 
metres apart to ensure that the ELF-EMF in the room in which mice were exposed to ELF-EMF did 
not reach the room containing the control treatment group of mice. Furthermore, to avoid 
interference with the ELF-EMF, no other metal components were used in the construction of either of 
the two treatment rooms. 
The environmental conditions of the respective treatment rooms are centrally controlled in the 
Animal Unit. For these experiments, a 12-hour day-night cycle was implemented. The two treatment 
rooms were also kept at a temperature ranging from 18 to 22°C and a humidity of 50 ± 10%. 
Furthermore, each treatment room was supplied with a constant flow of filtered air. A concerted 
© Central University of Technology, Free State
C h a p t e r  3 :  M a t e r i a l s  a n d  M e t h o d s  P a g e  | 36 
 
effort was made to keep noise to a minimum so that the stress levels of the animals were as kept as 
low as possible. 
Access to the treatment rooms was kept to a minimum and restricted to researchers participating in 
the project. Researchers wore protective clothing; masks and gloves, when entering treatment 
rooms. At the entrance of each treatment room, a sterilising footbath was placed into which a 
researcher stepped before entering a treatment room.  
3.3.3 Animal exposure cylinders 
For the exposure of mice to ELF-EMF, specific housing cylinders were designed. Each housing 
cylinder could contain three mice cages. These housing cylinders were constructed from polyvinyl 
chloride (PVC) and were approximately 120 cm long with a diameter of 30 cm. Each cylinder was 
perforated along its length with evenly spaced 2 cm diameter holes to provide light and air to the 
mice. To supply the ELF-EMF, 30 coils of copper wire were coiled around each of the PVC cylinders 
(Figure 3.2).  
 
Figure 3.2 Treatment room showing blue PVC cylinders containing animal cages. 
  The copper wiring coils are clearly visible around a PVC cylinder. 
Copper wiring coiled 
around cylinder 
containing mouse 
cages
Cylinder 
containing mouse 
cages on wooden 
table
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Three specifically designed mice cages were stacked on top of one another in each PVC cylinder. 
Each of the mice cages was placed on wooden rods that were threaded through holes in the PVC 
cylinder. These mice cage containing PVC cylinders were then placed on wooden tables in the two 
treatment rooms. The control treatment room contained four PVC cylinders, while the ELF-EMF 
exposure room contained 12 PVC cylinders. 
The 12 PVC cylinders in the ELF-EMF exposure room were connected to an electromagnetic field 
generator. This electromagnetic field generator was supplied by Immunent Signal System, Chamber 
of Commerce register number 17137077 and patent number WO 03/035176. The electrical signal 
from the Immunent Signal System was delivered to the copper coils surrounding each of the PVC 
cylinders providing electromagnetic field homogeneity of < 0.4% over the mice cages (Figure 3.3). At 
the centre of a particular PVC cylinder coil, the mean magnetic flux density was 5 µT. The magnetic 
flux density was checked daily by an engineer with a F.W. Bell Gauss/Tesla meter probe. Outside 
the PVC cylinders, the magnetic flux density diminished rapidly and did not overlap with adjacent 
PVC cylinders. Heat or sound development was negligible at this low magnetic flux density. 
 
Figure 3.3 Immunent signal system with PVC cylinder with copper coils. 
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PVA cylinder with 
copper coils
Wooden rods 
supporting a mice cage
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3.3.4 Animal cages 
The mice were housed in polypropylene mouse cages. These cages were specially designed to fit 
inside a PVC cylinder. A mouse cage was approximately 23 cm long, 15 cm wide and 12.5 cm high 
(Figure 3.4). To ensure that animals were not shocked during exposure, all parts of a mouse cage 
was non-metallic. The Perspex mouse cage lid comprised of two small troughs; one of the troughs 
contained the feeding pellets and the other for the water bottle.  
 
Figure 3.4  Specially designed polypropylene mouse cage. 
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3.4 Methods 
3.4.1 Set up of experimental trials 
For this project, mice were randomly selected for each of the two experimental trials from four-week- 
old male mice. Before the random selection of mice commenced; a weight range was determined 
which was used to guide the selection of mice. This weight range was determined by weighing four 
hundred four week-old-male mice, and thereafter calculating the mean weight and standard 
deviation. For both experimental trials, only mice weighing within the range of the mean weight of the 
400 mice + two standard errors were chosen. Thus, the weights of all mice used in this study ranged 
from 26.03 to 27.99 g (?̅?  ±  2𝑆𝐸; 27.01 ± 0.98).  
Both experimental trials comprised of four treatments. One treatment was considered to be the 
control treatment, in which the mice were not exposed to ELF-EMF (0-hour control treatment). The 
other treatments comprised of exposure to ELF-EMF for one hour (1-hour treatment), four hours (4-
hour treatment) and continuous exposure for 24 hours (24-hour treatment). For each treatment, 25 
mice were randomly selected. Mice falling within the weight range were assigned to each of the four 
treatments one-by-one in rotation for a particular experimental trial. Once mice had been assigned to 
the respective treatments, an analysis of variance was performed to ascertain if the mean weights of 
the different treatment groups within each experimental trial were not significantly different. The 
ANOVA tests revealed that there were no significant differences (p > 0.05) between the mean 
weights of the treatment groups within each of the two experimental trials. 
One of the two treatment rooms was designated for the ELF-EMF exposure treatments, while the 
other treatment room was designated for the control treatments of the experimental trials. The two 
experimental trials were conducted sequentially, with Experimental Trial 1 (1-week ELF-EMF 
exposure) conducted before Experimental Trial 2 (12-weeks ELF-EMF exposure). In the ELF-EMF 
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exposure treatment room the three treatments were applied concurrently; with the 1-hour and 4-hour 
treatments commencing at 08:00 daily. The continuous exposure treatment (24-hour treatment) was 
applied continuously for one week in Experimental Trial 1 and for 12 weeks in Experimental Trial 2.  
3.4.2 Mice care 
The mice used in this study were cared for according to the specifications of the Animal Unit. These 
specifications are based upon the instructions described by the Animal Protection Act 71 of 1962 
(South-African Goverment 1962). The diet of the mice comprised of specifically formulated food 
pellets produced by Epol®. Access to food and water was not restricted. Both the feeding pellet 
toughs and water bottles were replenished daily. The bottom of a mice cage was also covered with 
pine shavings. 
For Experimental Trial 1, the cages were not cleaned during the week of exposure, however, for 
Experimental Trial 2, all cages were cleaned at the end of all the weeks, except for the last week, at 
which time the mice were sacrificed. During the cleaning process, disruption of a treatment was kept 
at a minimum. To ensure minimal disruption, clean cages were prepared beforehand and the 
exchange for clean cages executed as fast as possible. The mice cages of each PVC cylinder were 
exchanged for clean cages one cylinder at a time. Firstly, each of the three cages in a PVC cylinder 
was removed from the cylinder and marked as “1”, “2” and “3”, where “1” indicated the top cage, “2” 
the middle cage and “3” the bottom cage. Mice were removed from their respective cages and 
placed into a clean cage with the same number. To establish rotation of the position of cages in the 
PVC cylinder, the clean cages were then returned to another position in the PVC cylinder in a 
systematic manner. The clean cages were returned to a PVC cylinder in the order of cage “2” at the 
bottom, “1” in the middle and “3” on top. 
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3.4.3 Blood collection  
The effect of ELF-EMF was studied on 15 blood parameters. These parameters included four 
erythrocyte parameters, thrombocytes, six leucocytes parameters and four immunophenotyping 
cluster of differentiation (CD) classes (Table 3.1). 
 
Table 3.1 Blood parameters assessed for the effect of ELF-EMF. 
Erythrocyte and thrombocyte 
parameters 
Leucocyte parameters CD parameters 
Erythrocyte count (RBC) Total leucocyte count CD3 
Haemoglobin (HGB) Lymphocyte count CD4 
Haematocrit (HCT) Monocyte count CD8 
Mean corpuscular volume (MCV) Neutrophil count CD19 
Thrombocyte count Eosinophil count  
 Basophil count  
 
To assess the effect of ELF-EMF on the 15 blood parameters, blood was collected from the mice 
after the completion of the two trials. The mice cages were taken to the surgery of the Animal Unit 
one-by-one. Blood was collected from each mouse in a cage as fast as possible to limit any stress. 
This was achieved by first anaesthetising all the mice from a cage by placing them in a desiccator 
containing a cotton wool ball drenched with halothane (3-5%). Blood was collected from a mouse 
through orbital bleeding (Everds and Bollinger 2012; Hoggatt et al. 2016). Pressure was applied to 
the skull of a mouse to force out an eye, which was then removed with a forceps. Thereafter, 
approximately 1 ml of blood was collected from the orbital cavity in a blood collecting tube containing 
ethylenediaminetetraacetic acid (EDTA) anticoagulant powder and gently mixed. At the end of the 
blood collecting procedure, a mouse had usually died from exsanguination, but not withstanding the 
neck was dislocated. Each 1 ml blood tube was then gently mixed, after which 0.5 ml of blood was 
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removed with a syringe and decanted into a cuvette. Both 0.5 ml containers where then marked in 
an appropriate manner. The blood containing tubes were immediately placed on ice in an icebox and 
transported to the laboratories where the respective blood parameters were measured within 24 
hours. Half of the blood containing cuvettes were sent to the National Health Laboratory Services 
(NHLS) at the University of the Free State, Bloemfontein, for the CD parameter measurements. The 
other half of the blood containing cuvettes were sent to the haematology laboratory of the Central 
University of Technology, Free State, to measure the remainder of the blood parameters. 
3.4.4 Blood parameter measurements 
The blood parameters, excluding the CD parameters, were analysed with a PENTRA 60C(+) fully 
automated haematology analyser (Horiba ABS, PENTRA 80, Paris, France). The PENTRA 60C(+) is 
a small bench-top instrument with single sample capability. It provides a complete blood cell (CBC) 
count, including a five-part differential (5-DIFF) count, as well as counts of two leucocyte 
subpopulations; the large immature cells (LIC) and atypical lymphocytes (ALY). Blood samples 
destined for analysis by the PENTRA 60C(+) were uninterruptedly rotated gently on rollers to 
prevent coagulation. The PENTRA 60C(+) was operated in the CBC + 5DIFF mode, to include a 
five-part differential count of the leucocytes. From a particular blood sample, 53 µl of the blood were 
aspirated with a sampling probe and then divided into three blood samples; which were then 
distributed to three respective chambers with reagents where the measurements were made (Table 
3.2).  
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Table 3.2 Blood parameters measured in the three different chambers using the CBC+  
  5DIFF mode of the PENTRA 60C(+). 
Chambers Parameter Parameter description 
1 WBC White blood cell 
 LYM Lymphocyte % and number 
 MON Monocyte % and number 
 NEU Neutrophil % and number 
 EOS Eosinophil % and number 
 BAS Basophil % and number 
 LIC Large immature cell % and number 
 ALY Atypical lymphocyte % and number 
2 RBC Red blood cell 
 HGB Haemoglobin concentration 
 HCT Haematocrit 
 MCV Mean corpuscular volume 
 MCH Mean corpuscular haemoglobin 
 MCHC Mean corpuscular haemoglobin concentration 
 RDW Red distribution width 
3 PLT Platelets 
 RDW Platelet distribution width 
 MPV Mean platelet volume 
 PCT Plateletcrit 
  
The blood samples were analysed one-by-one. After analysing a blood sample, a computer 
generated result was produced of the respective haematological measurements as indicated in 
Table 3.3.  
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Table 3.3  Example of a PENTRA 60C(+) Differential mode haematology analyser result. 
Parameter Measurement 
Measurement 
unit 
Normal ranges (NR) 
WBC 6.2 103/mm3 4.0 / 11.0 
RBC 5.5 106/ mm3 4.00 /6.20 
HGB 16.2 g/dl 11.0 /18.8 
HCT 49.6 % 35.0 / 55.0 
MCV 89 µm3 80 / 100 
MCH* 29.3 pg 26.0 / 34.0 
MCHC* 32.8 g/dl 31.0 / 35.0 
RDW* 21.8 h % 10.0 / 20.0 
PLT 225 103/mm3 150 / 400 
MPV* 9.9 µm3 6.0 / 10.0 
PCT* 0.22 % 0.200 / 0.500 
PDW* 18.8 h % 8.0 / 18.0 
 % 
True value 
103/mm3 
% NR 
True value 
NR 103/mm3 
LYM% 32.7 2.01 25.0 / 50.0 1.00 / 5.00 
MON% 5.7 2.0 2.0   / 10.0 0.10 / 1.00 
NEU% 58.4 3.60 50.0 / 80.0 2.00 / 8.00 
EOS% 1.3 0.08 0.0   / 5.0 0.00 / 0.40 
BAS% 1.9 0.12 0.0  /  2.0 0.00 / 0.20 
     
ALY%* 1.4 0.08 0.0  /  2.0 0.00 / 0.20 
LIC%* 0.4 0.02 0.0  /  2.0 0.00 / 0.20 
 * = Blood parameters that were not included in this study; h = Above normal ranges; NR = normal range 
The CD blood parameters were analysed with a BD FACSCalibur flow cytometer: This flow 
cytometer is a multicolour flow cytometry system that performs both analysis and sorting in one 
benchtop system. The BD FACSCalibur system is a highly sensitive tool, providing laboratories with 
the technological capabilities required for cellular and molecular work in areas such immune 
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function, genetics and proteomics. Flow cytometry is a technology that simultaneously measures 
and then analyses multiple physical characteristics of single particles, usually cells, as they flow in a 
fluid stream through a beam of light. The characteristics are determined using an optical-to-
electronic coupling system that records how the cell or particle scatters incident laser light and emits 
fluorescence. The argon ion laser is commonly used in flow cytometry, because the 488 nm light that 
it emits excites more than one fluorochrome. The commonly used fluorochromes, fluorescein 
isothiocyanate (FITC) and phycoerythrin (PE) were used in this study to label the CD parameters. 
The combination of the fluorochromes, FITC and PE, can be exited simultaneously, generating peak 
emission wavelengths at 520 nm for FITC and 575 nm for PE, which are far enough apart so that 
each signal can be detected by a separate detector. The amount of fluorescent signal detected is 
proportional to the number of fluorochrome molecules on the particle. For the detection of the CD 
parameters, CD3, CD4, CD8 and CD19, FITC and PE fluorescent dyes were conjugated to a 
monoclonal antibody and used to identify a particular cell type based on the individual antigenic 
surface markers of the cell (Table 3.4). The staining pattern produced by each cell subpopulation, 
combined with data from forward-scattered light and side-scattered light were used to identify which 
cells were present in a sample and to count their relative percentages.  
Table 3.4 CD parameters, monoclonal antibodies and fluorochromes used in the study.  
Parameter Monoclonal antibody Fluorochrome Manufacturer 
CD3 IgG2a FITC Becton Dickinson 
CD4 IgG2b PE Becton Dickinson 
CD8 IgG2a PE Becton Dickinson 
CD19 IgG2a PE Becton Dickinson 
Mouse Control IgG2a FITC Becton Dickinson 
Mouse Control IgG2a PE Becton Dickinson 
Mouse Control (Clone A-1) IgG2a PE Becton Dickinson 
  FITC = fluorescein isothiocyanate; PE = phycoerythrin  
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3.5 Data analysis 
Several statistical analyses were performed on the data that were generated in this study. These 
analyses included the following: 
 Summary statistics were calculated for all 15 blood parameters that were measured in 
Experimental Trial 1 and Experimental Trial 2; 
 analysis of variance (ANOVA) tests were performed to ascertain if significant differences 
existed between treatments of a particular blood parameter within a particular experimental 
trial; 
 Tukey HSD tests were performed after ANOVA tests that were found to be significant. 
These test were performed to reveal witch combinations of treatments were significantly 
different from one another; and 
 t-tests were performed to ascertain if significant differences existed between equivalent 
treatments of the two experimental trials. 
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Erythrocytes and Thrombocytes 
4.1 Introduction 
The erythroid lineage is responsible for the formation of erythrocytes, (red blood cells; RBC), and 
thrombocytes (platelets; PLT). These blood cells originate from a common myeloid progenitor 
(Figure 4.1). The RBC are responsible for the transport of oxygen to tissue cells, while the platelets 
are central to this haemostatic balance, support of coagulation, and also show anti-fibrinolytic 
effects. 
 
Figure 4.1 Erythrocyte and thrombocyte lineage. 
 
Common myeloid
progenitor
Multipotential
haematopoietic stem cell
Megakaryocyte Erythrocyte
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Several studies in rats and mice have shown that ELF-EMF may affect erythrocyte parameters, and 
thrombocytes. Mice exposed to ELF-EMF for 8 to10 hours/day for of 7, 14, 28, 42 and 56 days, 
demonstrated decreased numbers of red blood cells and haemoglobin concentrations up to 42 days 
of exposure (Singh et al. 2013). This study further showed that all changes appeared to normalise 
during the last two weeks of the 56-day exposure group. Rats exposed for 3 hours/day over 50 and 
100 days showed that haemoglobin concentrations and mean platelet volumes (MPV) significantly 
decreased in rats that were exposed to ELF-EMF for 50 days when compared to a control group 
(Cakir et al. 2009). When the 50-day exposure group was compared to the 100-day exposure group, 
it was noticed that MPV levels were significantly lower in the 100-day exposure group. The number 
of red blood cells, haematocrit and number of platelets did not demonstrate significant differences. 
Hashish et al. (2008) also showed that in mice exposed continuously for 30 days to ELF-EMF, the 
number of platelets decreased. In contrast to these studies, Amara et al. (2006) showed that the 
levels of haemoglobin, red blood cells and number of platelets increased significantly in rats exposed 
for 1-hour/day for 30 consecutive days. Rats exposed continuously to ELF-EMF for 15, 30 and 45 
days showed changes in osmotic fragility and shape of red blood cell membranes and haemoglobin 
(Ali et al. 2003). These results indicated that exposure of the animals to ELF-EMF resulted in the 
decrease of red blood cell membrane elasticity and permeability and in changes in the molecular 
structure of haemoglobin. After the removal from the ELF-EMF, the animals did not show signs of 
repair in the newly generated red blood cell structure, indicating that the blood generating system 
was severely impaired.  
 
In this study, mice were exposed to ELF-EMF for one week (Experimental Trial 1) and twelve weeks 
(Experimental Trial 2). The different treatment groups involved exposure for 1-hour, 4-hours and 
continuously. The effects of ELF-EMF were measured for five different erythrocyte and thrombocyte 
parameters and then compared to the excepted normal ranges for mice as listed in Table 4.1. 
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Table 4.1 Erythrocyte and parameters and normal ranges in mice.  
  (Everds and Bollinger 2012). 
 
Parameter Unit Normal mouse range 
Erythrocyte count (RBC) Number of cells × 106/mm3 7–11 × 106/mm3 
Haemoglobin concentration (HGB)  Grams per decilitre (g/dl) 13–18 g/dl 
Haematocrit (HCT) Percentage (%) 40–60% 
Mean corpuscular volume (MCV) Femtolitre (fl) 40–55 fl 
Thrombocyte count (PLT) Number of platelets × 103/mm3 900–2000 × 103/mm3 
 
4.2 Experimental Trial 1: One-week exposure 
Overall, no distinguishing patterns emerged for the four treatment groups of the different erythrocyte 
and thrombocyte parameters. The range values were, for the most, similar for each of the treatment 
groups, however for the parameters RBC, HGB and HCT the largest range values were recorded for 
the 1-hour and 4-hour ELF-EMF exposure treatment groups (Table 4.2). Besides the PLT, all means 
of the remaining parameters fell within the normal range for mice (Everds and Bollinger 2012). The 
PLT measurements were marginally less than the normal range. 
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Table 4.2 Summary statistics of erythrocyte and thrombocyte parameters of   
  Experimental Trial 1.  
Variable 
Treatment 
group 
Minimum Maximum Range Mean 
Standard 
deviation 
RBC 
0-H (control) 8.40 10.30 1.90 9.23 0.49 
1-H 7.70 10.10 2.40 9.21 0.52 
4-H 8.10 10.20 2.10 9.26 0.53 
24-H 8.90 9.90 1.00 9.32 0.28 
HGB 
0-H (control) 13.60 16.20 2.60 14.75 0.64 
1-H 12.40 15.70 3.30 14.66 0.79 
4-H 12.80 16.10 3.30 14.76 0.71 
24-H 13.90 15.90 2.00 14.76 0.51 
HCT 
0-H (control) 39.30 48.00 8.70 43.72 2.33 
1-H 37.90 48.10 10.20 43.86 2.45 
4-H 37.50 48.30 10.80 43.88 2.60 
24-H 41.80 46.90 5.10 44.12 1.37 
MCV 
0-H (control) 46.00 48.00 2.00 47.29 0.55 
1-H 46.00 49.00 3.00 47.60 0.65 
4-H 46.00 48.00 2.00 47.32 0.56 
24-H 47.00 48.00 1.00 47.48 0.51 
PLT 
0-H (control) 347.00 1,205.00 858.00 853.63 225.15 
1-H 500.00 1,254.00 754.00 883.12 175.44 
4-H 428.00 1,119.00 691.00 837.12 172.52 
24-H 457.00 1,023.00 566.00 824.77 122.14 
RBC = Red blood cell count; HGB = Haemoglobin; HCT = Haematocrit; MCV = Mean corpuscular value; PLT = Platelet 
count; H = Hour 
 
ANOVA tests were performed to ascertain if significant differences existed between the different 
treatment groups of the different erythrocyte and thrombocyte parameters. All of the ANOVA tests 
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revealed that no significant differences existed between any of the treatments for all parameters at α 
= 0.05 (Table 4.3). 
Table 4.3 ANOVA tests performed on the erythrocyte and thrombocyte parameters of  
  Experimental Trial 1. 
Parameter Source 
Sum of 
squares 
Degrees 
of 
freedom 
Mean 
square 
F P-value 
RBC 
Between groups 0.15 3 0.05 0.23 0.88 
Within groups 20.65 95 0.22   
Total 20.80     
HGB 
Between groups 0.17 3 0.06 0.13 0.94 
Within groups 42.84 95 0.45   
Total 43.01 98    
HCT 
Between groups 2.04 3 0.68 0.14 0.94 
Within groups 476.75 95 5.02   
Total 478.81 98    
MCV 
Between groups 81.07 3 27.02 1.19 0.32 
Within groups 2,177.68 96 22.68   
Total 2,258.75 99    
PLT 
Between groups 50,337.24 3 16,779.08 0.44 0.72 
Within groups 3,609,366.00 95 37,993.33   
Total 3,659,703.45 98    
RBC = Red blood cell count; HGB = Haemoglobin; HCT = Haematocrit; MCV = Mean corpuscular value; PLT = Platelet 
count 
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4.3 Experimental Trial 2: Twelve-week exposure 
In contrast with the Experimental Trial 1, a few distinguishing patterns could be discerned for the 
different treatment groups of the different erythrocyte and thrombocyte parameters measured in 
Experimental Trial 2. The range values of RBC, HGB and HCT demonstrated a tendency to increase 
towards the higher ELF-EMF exposure times (Table 4.4). The range values of the 1-hour and 4-hour 
ELF-EMF treatment groups for HCT were approximately double that of the control treatment group, 
while the range value of the 24-hour ELF-EMF treatment group was approximately four times greater 
than that of the control treatment group. In contrast for MCV, a decrease in range values was noted 
for the higher ELF-EMF exposure times. For all erythrocyte and thrombocyte parameters, except for 
PLT, the mean values were relatively similar for all treatment groups. For the PLT, the mean number 
of PLT demonstrated a decrease with an increase in the ELF-EMF exposure times. Besides the 
PLT, the means of the remaining parameters fell within the normal range for mice (Everds and 
Bollinger 2012). The PLT measurements were marginally less than the normal range. 
Table 4.4 Summary statistics of erythrocyte and thrombocyte parameters of   
  Experimental Trial 2. 
Variable 
Treatment 
group 
Minimum Maximum Range Mean 
Standard 
deviation 
RBC  
0-H (control) 8.17 10.10 1.93 9.21 0.59 
1-H 7.33 10.49 3.16 9.27 0.68 
4-H 7.56 11.06 3.50 9.48 0.83 
24-H 3.38 11.01 7.63 9.23 1.38 
HGB 
0-H (control) 13.50 16.60 3.10 14.77 0.85 
1-H 13.00 16.30 3.30 14.68 0.90 
4-H 12.00 17.50 5.50 15.05 1.34 
24-H 5.30 17.20 11.90 14.54 2.16 
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Variable 
Treatment 
group 
Minimum Maximum Range Mean 
Standard 
deviation 
HCT 
0-H (control) 39.70 48.40 8.70 44.08 2.63 
1-H 34.10 49.70 15.60 43.63 3.33 
4-H 35.40 52.60 17.20 44.98 4.20 
24-H 15.60 54.00 38.40 43.83 6.83 
MCV 
0-H (control) 46.00 55.00 9.00 47.88 1.99 
1-H 46.00 48.00 2.00 47.08 0.58 
4-H 47.00 48.00 1.00 47.48 0.51 
24-H 44.30 48.00 3.70 46.85 0.77 
PLT 
0-H (control) 325 983 658 813.63 157.36 
1-H 254 1,115 861 803.13 193.33 
4-H 399 1,024 625 771.60 171.00 
24-H 383 1,094 711 708.83 191.05 
RBC = Red blood cell count; HGB = Haemoglobin; HCT = Haematocrit; MCV = Mean corpuscular value; PLT = Platelet; 
H = Hour  
 
ANOVA tests were performed to ascertain if significant differences existed between the different 
treatment groups of the different erythrocyte and thrombocyte parameters measured in Experimental 
Trial 2. Highly significant differences could only be identified for the parameter MCV at α = 0.05 
(Table 4.5). All other parameters did not reveal significant differences. 
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Table 4.5 ANOVA tests performed on the erythrocyte and thrombocyte parameters of  
  Experimental Trial 2. 
Parameter Source 
Sum of 
squares 
Degrees of 
freedom 
Mean 
square 
F P-value 
RBC 
Between groups 1.11 3 0.73 0.41 0.74 
Within groups 76.25 85 0.89   
Total 77.36 88    
HGB 
Between groups 3.51 3 1.17 0.56 0.64 
Within groups 180.13 86 2.09   
Total 183.64 89    
       
HCT 
Between groups 28.00 3 9.33 0.43 0.76 
Within groups 1,859.52 86 21.62   
Total 1,887.52 89    
MCV 
Between groups 11.99 3 3.99 3.93 0.01 
Within groups 87.71 86 1.01   
Total 99.71 89    
PLT 
Between groups 146,529.06 3 48,843.02 1.52 0.22 
Within groups 2,735,022.92 85 32,176.74   
Total 2,881,551.97 88    
*RBC = Red blood cell count; HGB = Haemoglobin; HCT = Haematocrit; MCV = Mean corpuscular value; PLT = Platelet 
count 
A Tukey HSD test was performed on the MCV data to determine which of the different treatment 
pairs differed from one another at α = 0.05. This test revealed that the control treatment and 24-hour 
exposure treatment groups demonstrated highly significant differences (p = 0.01). 
4.4 Comparison of Experimental Trial 1 and Experimental Trial 2 
Most of the ranges (70%) of the measurements of the erythrocyte and thrombocyte parameters were 
larger (wider) in Experimental Trial 2, when compared to Experimental Trial 1. In contrast, only 45% 
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of the means of the erythrocyte and thrombocyte parameters of Experimental Trial 2 were greater 
than the means of Experimental Trial 1 (Table 4.6). For the parameters RBC number, HGB and 
HCT; the smallest differences between the ranges of Experimental Trial 1 and 2 were recorded for 
the control treatment groups and the highest differences between ranges for the 24-hour treatment 
groups. In contrast, the largest differences between ranges were recorded for the control treatment 
groups for the parameters MCV and PLT. The 24-hour treatment group of HCT showed an 
exceptionally high value for the difference between the ranges, which was more than five times 
greater than that of the 1-hour and 4-hour treatment groups. The largest differences between means 
of Experimental Trial 1 and 2 were recorded for the 4-hour treatment groups of RBC, HGB and HCT, 
while for MCV and PLT the 24-hour treatment groups demonstrated the largest differences between 
means. 
 
Table 4.6 Comparison of ranges and means between Experimental Trials 1 and 2.  
Variable 
Treatment 
group 
Range 
Exp. 1 
Mean 
Exp. 1 
Range 
Exp. 2 
Mean 
Exp. 2 
Difference 
between 
ranges 
Difference 
between 
means 
RBC 
0-H (control) 1.90 9.23 1.93 9.21 -0.03 0.02 
1-H 2.40 9.21 3.16 9.27 -0.76 -0.06 
4-H 2.10 9.26 3.50 9.48 -1.40 -0.22 
24-H 1.00 9.32 7.63 9.23 -6.60 0.09 
HGB 
0-H (control) 2.60 14.75 3.10 14.77 -0.50 -0.02 
1-H 3.30 14.66 3.30 14.68 0.00 -0.02 
4-H 3.30 14.76 5.50 15.05 -2.20 -0.29 
24-H 2.00 14.76 11.90 14.54 -9.90 0.22 
HCT 
0-H (control) 8.70 43.72 8.70 44.08 0.00 -0.36 
1-H 10.20 43.86 15.60 43.63 -5.40 0.23 
4-H 10.80 43.88 17.20 44.98 -6.40 -1.1 
24-H 5.10 44.12 38.40 43.83 -33.30 0.29 
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Variable 
Treatment 
group 
Range 
Exp. 1 
Mean 
Exp. 1 
Range 
Exp. 2 
Mean 
Exp. 2 
Difference 
between 
ranges 
Difference 
between 
means 
MCV 
0-H (control) 2.00 47.29 9.00 47.88 -7.00 -0.59 
1-H 3.00 47.60 2.00 47.08 1.00 0.52 
4-H 2.00 47.32 1.00 47.48 1.00 -0.16 
24-H 1.00 47.48 3.70 46.85 -2.70 0.63 
PLT 
0-H (control) 858.00 853.63 658 813.63 200 40 
1-H 754.00 883.12 861 803.13 -107 79.99 
4-H 691.00 837.12 625 771.60 66 65.52 
24-H 566.00 824.77 711 708.83 -145 115.94 
RBC = Red blood cell count; HGB = Haemoglobin; HCT = Haematocrit; MCV = Mean corpuscular value; PLT = Platelet 
count; H = Hour; Exp. 1 = Experimental Trial 1; Exp. 2 = Experimental Trial 2 
T-tests were performed to ascertain if the respective treatments of a particular parameter in 
Experimental Trial 1 differed significantly from the equivalent treatment in Experimental Trial 2. 
These t-tests revealed that a few of the comparisons were significantly different at α = 0.05 (Table 
4.7). For the parameter HGB, all the ELF-EMF exposure treatment groups (1-hour, 4-hour and 24-
hour) showed highly significant differences between the two experimental trials. For the number of 
PLT, only the 24-hour treatment group was highly significant. The parameter MCV revealed highly 
significant differences between the 4-hour treatment groups, as well as between the 24-hour 
treatment groups of the two experimental trials.  
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Table 4.7 T-tests comparing the erythrocyte and thrombocyte parameters of  
  Experimental Trials 1 and 2. 
Parameter 
Treatment 
group 
df t P-value 
RBC 
0-H  28 0.12 0.90 
1-H 45 -0.27 0.78 
4-H 41 -1.12 0.27 
24-H 25 0.30 0.76 
HGB 
 
0-H  26 -0.09 0.92 
1-H 25 -41.44  < 0.0001 
4-H 25 -35.45  < 0.0001 
24-H 25 -20.76  < 0.0001 
HCT 
 
0-H  29 -0.43 0.66 
1-H 42 0.31 0.76 
4-H 40 -1.11 0.27 
24-H 25 0.20 0.83 
MCV 
0-H  17 -1.14 0.27   
1-H 47 2.94   < 0.01 
4-H 48 -1.06 0.29 
24-H 40 3.38 < 0.001 
PLT 
0-H  38 0.66 0.51 
1-H 45 1.49 0.14 
4-H 48 1.35 0.18 
24-H 39 3.02 < 0.001 
  RBC = Red blood cell count; HGB = Haemoglobin; HCT = Haematocrit;  
  MCV = Mean corpuscular value; PLT = Platelet count; H = Hour  
 
A visual perspective of the mean percentages of the respective exposure treatment groups of the 
two experimental trials shows a number of identifiable differences. Parameters RBC, HGB, HCT and 
MCV demonstrated lower mean values for the 4-hour treatment group in Experimental Trial 1 when 
compared to the 4-hour groups of Experimental Trial 2 (Figure 4.2). In contrast, for the same 
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parameters, the 24-hour treatment group demonstrated higher mean values in Experimental Trial 1 
when compared to those of Experimental Trial 2. When considering the control treatment groups of 
HGB, HCT and MCV, the mean values in Experimental Trial 1 were lower than those of 
Experimental Trial 2. For the PLT count, the Experimental Trial 1 mean values were all greater than 
the Experimental Trial 2 mean values.  
a. RBC     b.    HGB 
 
          
 
c.    HCT d. MCV                       
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e.    PLT 
  
Figure 4.2  Bar graph of the comparison of Experimental Trial 1 and 2 mean values of the 
  different RBC and PLT parameters. 
4.5 Discussion  
This study showed that ELF-EMF had relatively negligible effects on the erythrocyte and 
thrombocyte parameters of mice exposed to ELF-EMF for one week, as well as for twelve weeks. 
MCV was the only parameter that showed significant differences between the control treatment 
group and the 24-hour treatment group in the 12-week experimental trial. This result indicated that 
the mean volume of the red blood cells deceased, although slightly, during the 12-week 
experimental trial.  
The results suggest that ELF-EMF may affect red blood cells in various ways. Hashish et al. (2008) 
demonstrated that ELF-EMF caused a decrease in the number of red blood cells in mice, which was 
similar to what Amara et al. (2006) showed in rats after a lengthy period of ELF-EMF exposure. 
Furthermore, Ali et al. (2003) suggested that ELF-EMF caused changes in red blood cell membrane 
structure and permeability, which could explain the results found for MCV. Little changes could be 
demonstrated in the number of thrombocytes, which is in contrast to the reduction in the number of 
thrombocytes shown by Hashish et al. (2008) in mice and Cakir et al. (2009) in rats. Furthermore, 
the mean values of all parameters of both experimental trials were within the normal ranges for mice, 
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except for platelets (Everds and Bollinger 2012). In both experimental trials, the mean number of 
platelets was for all treatments marginally less than the minimum value of the normal range of the 
number of platelets for mice (Everds and Bollinger 2012); although all treatment groups of 
Experimental Trial 1 demonstrated slightly higher numbers of platelets when compared to 
Experimental Trial 2.  
A noteworthy outcome of this study was the number of significant differences recorded between the 
two experimental trials. Although only MCV demonstrated significant differences between ELF-EMF 
treatments in Experimental Trial 2, a number of significant differences were recorded for ELF-EMF 
treatments between the two experiments. These included HGB (1-hour, 4-hour and 24-hour 
treatments), MCV (1-hour and 24-hour treatments) and platelets (24-hour treatment). It is perhaps 
reasonable to speculate that the longer exposure in Experimental Trial 2 could have induced 
subclinical stress in the animals. Szemerszky et al. (2010) showed significant proopiomelanocortin 
elevation and depressive-like behaviour in rats following long-term ELF-EMF exposure, indicating 
that ELF-EMF may induce a subclinical stress condition. 
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Leucocytes 
5.1 Introduction  
Leucocytes, also known as white blood cells, are major roll players in the immune system. These 
cells are all nucleated, which distinguishes them from the anucleated erythrocytes and 
thrombocytes. They are involved in protecting the body against both infectious diseases and foreign 
invaders (Marieb and Hoehn 2016). Broadly, the leucocytes can be further divided into the five main 
cell types: neutrophils, eosinophils, basophils, monocytes and lymphocytes (Martini 2004). 
When leucocytes are classified by their structure, there are two categories; namely, the granulocytes 
and agranulocytes (Hall and Guyton 2011). The granulocytes are polymorphonulcear leucocytes and 
comprise of neutrophils, eosinophils and basophils, while the agranulocytes are mononulcear and 
comprise of monocytes and lymphocytes. Alternatively, the leucocytes can be classified by their 
lineage, as either being myeloid or lymphoid cells (Figure 5.1). The lymphocytes form the lymphoid 
cell lineage, while all the other leucocytes belong to the myeloid cell lineage (Hall and Guyton 2011). 
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Figure 5.1 Leucocyte lineage. 
 
Several studies in rats and mice have shown that ELF-EMF may affect leucocyte parameters. 
Studies where rats and mice were exposed continuously to ELF-EMF for one week, 15 weeks (de 
Kleijn et al. 2016) and for 120 days (Seto et al. 1986) revealed contradicting outcomes for the total 
number of leucocytes. In a one-week experiment, de Kleijn et al. (2016) demonstrated an increase in 
the number of leucocytes, while in a 15-week experiment no changes were demonstrated. Seto et al. 
(1986), on the other hand, showed a decrease in the number of leucocytes.  
Where rats and mice were exposed to ELF-EMF for short periods in a day, no particular patterns 
could be discerned for the respective leucocyte parameters. In a rat experiment where rats were 
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exposed for 3h/d for 50 and 100 days, no changes could be identified in the number of total 
leucocytes, as well as in the number of granulocytes and agranulocytes (Cakir et al. 2009). In a 
number of mice experiments, where mice were exposed to ELF-EMF for short periods in a day over 
varying number of days, contrasting results were demonstrated. In experiments were mice were 
exposed for 8 to10 hours/day for 7, 14, 28 and 42 days; Singh et al. (2012) showed an increase in 
the number of leucocytes and lymphocytes, while the number of monocytes and neutrophils 
decreased for all exposure periods. In contrast, Çetin et al. (2006) showed opposite results for the 
total number of leucocytes, lymphocytes and neutrophils. The number of neutrophils decreased 
similarly, to what Singh et al. (2012) had found. In an experiment where mice were exposed to ELF-
EMF for 30 minutes/day every other day for two weeks, the total number of monocytes decreased 
(Arafa et al. 2003). 
In a unique experiment, Bonhomme-Faivre et al. (1998a) exposed Swiss mice continuously to ELF-
EMF for 350 days. A number of haematological parameters was measured after 20, 43, 63, 90, 190 
and 350 days. On day 20, exposed animals showed a significant decrease in leucocyte, lymphocyte 
and monocyte counts. On days 43 and 63, no significant differences were observed in the leucocyte 
parameters, indicating haemopoetic recovery. On day 90, a significant fall in the total number of 
leucocytes, neutrophils and eosinophils was observed. On day 190, the exposed animals 
demonstrated neutropenia, while on day 350, no significant differences in the leucocyte parameters 
were observed, indicating that the animals had recovered.  
The effects of ELF-EMF were studied on six different leucocyte parameters in mice exposed for one 
week (Experimental Trial 1) and for twelve weeks (Experimental Trial 2). The results of the two 
experiments were compared with one another and to the excepted normal ranges of different 
leucocyte parameters in mice (Table 5.1). 
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Table 5.1 Leucocyte parameters and normal ranges in mice  
  (Everds and Bollinger 2012).  
Parameter Unit Normal mouse range 
Total leucocyte count Number of cells ×103/mm3 2–10 × 103/mm3 
Lymphocyte count Number of cells ×103/mm3 7–8 × 103/mm3  
Monocyte count Number of cells ×103/mm3 Minor cell type 
Neutrophil count  Number of cells ×103/mm3 2–3 × 103/mm3 
Eosinophil count Number of cells ×103/mm3 Minor cell type 
Basophil count Number of cells ×103/mm3 
Very rarely observed in 
peripheral blood 
 
 
5.2 Experimental Trial 1: One-week exposure 
Overall, a few distinguishing patterns emerged for the four treatment groups of the different 
leucocyte parameters. The range values were, for the most, similar for each of the treatment groups 
of total leucocytes, lymphocytes and basophils. The range values of the different treatment groups of 
monocytes demonstrated a tendency to increase towards the longer ELF-EMF exposure times. In 
contrast for the neutrophils, a decrease in range values was noted for the longer ELF-EMF exposure 
periods (Table 5.2). The mean values demonstrated a slight increase towards the longer ELF-EMF 
exposure times for total leucocytes, lymphocytes and eosinophils. The mean values of the 
neutrophils were substantially lower in the ELF-EMF exposure groups when compared to the control 
treatment group. Besides neutrophils, all the means of the measurements of the remaining 
parameters fell within the normal range for mice (Everds and Bollinger 2012). The neutrophil 
measurements were substantially less than the normal range for all treatment groups. 
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Table 5.2 Summary statistics of leucocyte parameters of Experimental Trial1. 
Variable 
Treatment 
group 
Minimum Maximum Range Mean 
Standard 
deviation 
Total  
leucocytes 
0-H (control) 3.20 9.00 5.80 6.33 1.39 
1-H 4.10 10.90 6.80 6.66 1.43 
4-H 4.46 9.50 4.90 7.06 1.44 
24-H 3.38 11.60 7.80 7.26 1.66 
Lymphocytes 
0-H (control) 2.69 8.02 5.33 5.51 1.27 
1-H 3.50 9.39 5.90 5.83 1.33 
4-H 3.87 8.68 4.81 6.20 1.37 
24-H 3.34 9.21 5.87 6.49 1.43 
Monocytes 
0-H (control) 0.06 0.37 0.32 0.20 0.09 
1-H 0.06 0.50 0.44 0.22 0.11 
4-H 0.09 0.79 0.70 0.23 0 .14 
24-H 0.06 1.58 1.52 0.23 0.29 
Neutrophils 
0-H (control) 0.32 0.93 0.61 0.57 0.15 
1-H 0.02 0.05 0.04 0.03 0.08 
4-H 0.02 0.05 0.03 0.03 0.07 
24-H 0.00 0.08 0.08 0.03 0.02 
Eosinophils 
0-H (control) 0.00 0.07 0.07 0.02 0.02 
1-H 0.35 0.88 0.54 0.57 0.14 
4-H 0.00 1.02 1.02 0.57 0.19 
24-H 0.23 0.78 0.55 0.49 0.18 
Basophils 
0-H (control) 0.01 0.04 0.03 0.03 0.01 
1-H 0.00 0.07 0.07 0.02 0.02 
4-H 0.00 0.08 0.08 0.02 0.02 
24-H 0.00 0.07 0.07 0.01 0.02 
 H = hour 
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To provide a visual perspective of the outcomes of the different ELF-EMF exposure treatment 
groups of the respective leucocyte parameters, a bar graph was constructed. The bar graph clearly 
demonstrates an increase in the total number of leucocytes, lymphocytes and eosinophils (Figure 
5.2). The total number of neutrophils was substantially higher in the control treatment group when 
compared to the ELF-EMF exposure treatment groups. The number of basophils appeared to remain 
relatively low in all treatment groups.  
 
Figure 5.2 Bar graph showing the mean values of the different leucocyte parameter 
treatments for Experimental Trial 1. 
 
ANOVA tests were performed to ascertain if significant differences existed between the different 
treatment groups of the different leucocyte parameters. The ANOVA tests revealed highly significant 
differences amongst the treatment groups for the number of neutrophils, eosinophils and basophils 
(Table 5.3).  
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Table 5.3 ANOVA tests performed on the leucocyte parameters of Experimental Trial 1. 
Parameter Source Sum of squares 
Degrees 
of 
freedom 
Mean square F P-value 
Total  
Leucocytes 
Between groups 12,623,290.91 3 4,207,763.64 1.91 0.13 
Within groups 209,445,800.00 95 2,204,692.63   
Total 222,069,090.90 98    
Lymphocytes 
Between groups 13,582,784.12 3 4,527,594.71 2.48 0.07 
Within groups 173,446,103.23 95 1,825,748.46   
Total 187,028,887.35 98    
Monocytes 
Between groups 11,816.98 3 3,938.99 0.13 0.94 
Within groups 2,988,472.48 95 31,457.61   
Total 3,000,289.46 98    
Neutrophils 
Between groups 5,249,030.02 3 1,749,676.67 334.82 < 0.0001 
Within groups 496,437.20 95 5,225.65   
Total 5,745,467.22 98    
Eosinophils 
Between groups 4,817,880.42 3 1,605,960.14 78.30 < 0.0001 
Within groups 1,866,440.30 91 20,510.33   
Total 6,684,320.72 94    
Basophils 
Between groups 22,723.42 3 7,574.47 15.41 < 0.0001 
Within groups 41,257.83 84 491.38   
Total 63,999.25 87    
 
Tukey HSD tests were performed to determine which pairs of treatment groups were significantly 
different at α = 0.05 for total number of neutrophils, eosinophils and basophils. Significant 
differences were found between the control treatment groups and all the ELF-EMF exposure 
treatment groups for the total number of neutrophils and eosinophils (Table 5.4). In contrast, for the 
basophils, significant differences were found between the control treatment group and the 1-hour 
treatment group; as well as between the 1-hour treatment group and the 4-hour and 24-hour 
treatment groups. 
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Table 5.4 Tukey HSD tests for number of neutrophils, eosinophils and  basophils. 
Neutrophils  Eosinophils  Basophils 
TG 0-H 1-H 4-H 24-H  TG 0-H 1-H 4-H 24-H  TG 0-H 1-H 4-H 24-H 
0-H      0-H      0-H     
1-H S     1-H S     1-H S    
4-H S NS    4-H S NS    4-H NS S   
24-H S NS NS   24-H S NS NS   24-H NS S NS  
S = significant; NS = non-significant; TG = treatment group; 0-H = control, 1-H = 1 hour, 4-H = 4 hours, 24-H = 24 hours 
 
5.3 Experimental Trial 2: Twelve-week exposure 
Similarly, to Experimental Trial 1, a number of distinguishing patterns could be discerned for the 
different treatment groups of the different leucocyte parameters measured in Experimental Trial 2. 
For the most, the range values determined in Experimental Trial 2 were similar to those of 
Experimental Trial 1, except for the number of monocytes for which the range values were 
substantially less when compared to Experimental Trial 1 (Table 5.5). Similarly, to Experimental Trial 
1, the mean values for the three parameters, total number of leucocytes, lymphocytes and 
eosinophils, were consistently lowest in the control treatment group. In contrast to Experimental Trial 
1, the mean number of monocytes was substantially lower in all treatment groups. Furthermore, the 
number of neutrophils was similar in all treatment groups, which was in contrast to Experimental 
Trial 1 where the control treatment group showed a relatively high number of neutrophils. Similarly, 
to the Experimental Trial 1, the number of basophils was exceptionally low in all treatment groups. 
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Table 5.5  Summary statistics of leucocyte parameters of Experimental Trial 2. 
Variable Treatment group Minimum Maximum Range Mean 
Standard 
deviation 
Total  
leucocytes 
0-H (control) 0.20 7.00 6.80 3.68 2.31 
1-H 2.20 6.40 4.20 4.07 1.34 
4-H 2.70 7.90 5.20 4.53 1.37 
24-H 1.10 8.00 6.90 5.43 1.71 
Lymphocytes 
0-H (control) 0.07 6.27 6.20 3.14 2.23 
1-H 1.74 5.80 4.13 3.67 1.28 
4-H 2.35 6.72 4.37 4.07 1.20 
24-H 1.02 7.21 6.19 4.98 1.59 
Monocytes 
0-H (control) 0.00 0.15 0.15 0.06 0.05 
1-H 0.01 0.12 0.11 0.06 0.03 
4-H 0.03 0.17 0.14 0.09 0.04 
24-H 0.02 0.14 0.12 0.09 0.03 
Neutrophils 
0-H (control) 0.00 0.08 0.08 0.01 0.02 
1-H 0.01 0.35 0.34 0.04 0.09 
4-H 0.00 0.04 0.04 0.01 0.01 
24-H 0.00 0.03 0.03 0.02 0.01 
Eosinophils 
0-H (control) 0.00 0.57 0.57 0.23 0.17 
1-H 0.17 0.47 0.30 0.30 0.09 
4-H 0.16 0.77 0.61 0.35 0.17 
24-H 0.06 0.59 0.53 0.34 0.12 
Basophils 
0-H (control) 0.00 0.02 0.02 0.01 0.01 
1-H 0.00 0.02 0.02 0.05 0.05 
4-H 0.00 0.21 0.21 0.02 0.05 
24-H 0.00 0.03 0.03 0.01 0.01 
H = hour 
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To provide a visual perspective of the outcomes of the different ELF-EMF exposure treatment 
groups of the respective leucocyte parameters, a bar graph was constructed. The bar graph 
demonstrates the gradual increase in the total number of leucocytes and lymphocytes from the 
control treatment group to the 24-hour ELF-EMF exposure treatment groups (Figure 5.2). The 
remainder of the leucocyte parameters showed relatively similar numbers in the respective treatment 
groups. 
 
Figure 5.3 Bar graph showing the mean values of the different leucocyte parameter 
treatments for Experimental Trial 2. 
 
Analysis of variance (ANOVA) tests were performed to ascertain if significant differences existed 
amongst the different treatment groups of the different leucocyte parameters at α = 0.05. All of the 
ANOVA tests revealed that no significant differences existed between any of the treatments for all 
parameters at α = 0.05 (Table 5.6). 
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Table 5.6 ANOVA tests performed on the erythrocyte and thrombocyte parameters of  
  Experimental Trial 2. 
Parameter Source 
Sum of 
squares 
Degrees 
of freedom 
Mean  
square 
F P-value 
Total  
leucocytes 
Between groups 18,960,507.94 3 6,320,169.31 1.28 0.27 
Within groups 344,299,492.06 70 4,918,564.17   
Total 363,260,000.00 73    
Lymphocytes 
Between groups 19,255,581.85 3 6,418,527.28 1.51 0.22 
Within groups 297,901,366.23 70 4,255,733.80   
Total 317,156,948.08 73    
Monocytes 
Between groups 6,815.89 3 2,271.96 1.26 0.29 
Within groups 126,039.63 70 1,800.57   
Total 132,855.52 73    
Neutrophils 
Between groups 4,272.95 3 1,424.32 0.69 0.56 
Within groups 111,266.55 54 2,060.49   
Total 115539.51 57    
Eosinophils 
Between groups 36,067.63 3 12,022.54 0.42 0.74 
Within groups 1,983,325.39 70 28,333.22   
Total 2,019,393.02 73    
Basophils 
Between groups 1,451.39 3 483.80 0.63 0.60 
Within groups 39,316.71 51 770.92   
Total 40,768.10 54    
 
5.4 Comparison of Experimental Trial 1 and Experimental Trial 2 
When the range values of the two experimental trials were compared, no distinguishing patterns 
could be identified. However, when the means of Experimental Trial 1 were compared to the means 
of Experimental Trial 2, it was noted that 79% of the means of the different treatment groups were 
greater in Experimental Trial 1 than those in Experimental Trial 2 (Table 5.7). For the parameters 
total number of leucocytes, lymphocytes and monocytes, the mean values of all the treatment 
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groups were greater in Experimental Trial 1, when compared to Experimental Trial 2. The control 
treatment group of the total number of neutrophils measured in Experimental Trial 1 was 
approximately fifty times greater than Experimental Trial 2, while all the measurements of the ELF-
EMF exposure treatment groups were relatively similar in the two trials. On the other hand, the 
control treatment group of the total number of eosinophils measured in Experimental Trial 2 was 
approximately ten times greater than Experimental Trial 1, while all the measurements of the ELF-
EMF exposure treatment groups were relatively similar in the two trials. 
Table 5.7 Comparison of ranges and means between Experimental Trials 1 and 2. 
Variable 
Treatment 
group 
Range 
Exp. 1 
Mean 
Exp. 1 
Range 
Exp. 2 
Mean 
Exp. 2 
Difference 
in ranges 
Difference 
in means 
Total  
leucocytes 
 
0-H (control) 5.80 6.33 6.80 3.68 -1.00 2.65 
1-H 6.80 6.66 4.20 4.07 2.60 2.59 
4-H 4.90 7.06 5.20 4.53 -0.30 2.53 
24-H 7.80 7.26 6.90 5.43 0.90 1.83 
Lymphocytes 
 
0-H (control) 5.33 5.51 6.20 3.14 -0.87 2.37 
1-H 5.90 5.83 4.13 3.67 1.77 2.16 
4-H 4.81 6.20 4.37 4.07 0.44 2.13 
24-H 5.87 6.49 6.19 4.98 -0.32 1.51 
Monocytes 
 
0-H (control) 0.32 0.20 0.15 0.06 0.17 0.14 
1-H 0.44 0.22 0.11 0.06 0.33 0.16 
4-H 0.70 0.23 0.14 0.09 0.56 0.14 
24-H 1.52 0.23 0.12 0.09 1.40 0.14 
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Variable 
Treatment 
group 
Range 
Exp. 1 
Mean 
Exp. 1 
Range 
Exp. 2 
Mean 
Exp. 2 
Difference 
in ranges 
Difference 
in means 
 
Neutrophils 
 
0-H (control) 
 
0.61 
 
0.57 
 
0.08 
 
0.01 
 
0.53 
 
0.56 
1-H 0.04 0.03 0.34 0.04 -0.30 -0.01 
4-H 0.03 0.03 0.04 0.01 -0.01 0.02 
24-H 0.08 0.03 0.03 0.02 0.05 0.01 
Eosinophils 
 
0-H (control) 0.07 0.02 0.57 0.23 -0.5 -0.21 
1-H 0.54 0.57 0.30 0.30 0.24 0.27 
4-H 1.02 0.57 0.61 0.35 0.41 0.22 
24-H 0.55 0.49 0.53 0.34 0.02 0.15 
Basophils 
0-H (control) 0.03 0.03 0.02 0.01 0.01 0.02 
1-H 0.07 0.02 0.02 0.05 0.05 -0.03 
4-H 0.08 0.02 0.21 0.02 -0.13 0.00 
24-H 0.07 0.01 0.03 0.01 0.04 0.00 
H = Hour; Exp. 1 = Experimental Trial 1; Exp. 2 = Experimental Trial 2 
 
T-tests were performed to ascertain if the respective treatment groups of a particular leucocyte 
parameter of Experimental Trial 1 differed significantly from the equivalent treatment group in 
Experimental Trial 2. The t-tests revealed that most of the comparisons were highly significantly 
different at α = 0.05 (Table 5.8). No significant differences could be demonstrated for the 1-hour 
ELF-EMF exposure treatment group of the neutrophils, and both of the 4-hour and 24-hour ELF-
EMF exposure treatment groups of the basophils. 
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Table 5.8 T-tests comparing the leucocyte parameters of Experimental Trials 1 and 2. 
Parameter 
Treatment 
group 
df t P-value 
Total  
leucocytes 
 
0-H  20 4.00  0.0007 
1-H 38 5.71 < 00001 
4-H 39 5.56 < 0.001 
24-H 41 3.52   0.0011 
Lymphocytes 
 
0-H  20 3.69  0.0015 
1-H 38 5.03 < 0.001 
4-H 39 5.10 < 0.001 
24-H 41 3.26 0.0022 
Monocytes 
 
0-H  36 7.09  < 0.0001 
1-H 30 7.08  < 0.0001 
4-H 29 4.98  < 0.0001 
24-H 25 2.46  0.021 
Neutrophils 
0-H  24 18.36 < 0.0001 
1-H 14 -0.47   0.650 
4-H 39 6.10 < 0.0001 
24-H 39 4.49 < 00001 
Eosinophils 
 
0-H  15 -5.07  0.0001 
1-H 38 7.66 < 00001 
4-H 39 3.64   0.0007 
24-H 41 3.25   0.0023 
Basophils 
0-H  15 -3.22  0.0056 
1-H 29 3.64  0.0010 
4-H 18 -0.02   0.980 
24-H 38 1.96   0.057 
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A visual perspective of the mean number of cells of the respective treatment groups of the two 
experimental trials showed several identifiable differences. For the four parameters total leucocytes, 
lymphocytes, monocytes and basophils; the mean number of cells was substantially greater in 
Experimental Trial 1 than those in Experimental Trial 2 (Figure 5.4). The mean number of 
eosinophils was also greater in Experimental Trial 1, but only for the ELF-EMF exposure treatment 
groups. The mean number of neutrophils also demonstrated similar results, except for the 1-hour 
exposure treatment group, where the two trials showed similar mean cell counts. 
a. Total leucocyte count  b. Lymphocyte count 
   
c. Monocyte count d. Neutrophil count 
   
0
1
2
3
4
5
6
7
8
0-H 1-H 4-H 24-H
Trial 1
Trial 2
Exposure treatment group
N
u
m
b
er
 o
f 
ce
lls
 ×
10
3 /
m
m
3
Exposure treatment group
0
1
2
3
4
5
6
7
0-H 1-H 4-H 24-H
Trial 1
Trial 2
N
u
m
b
er
 o
f 
ce
lls
 ×
10
3 /
m
m
3
Exposure treatment group
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0-H 1-H 4-H 24-H
Trial 1
Trial 2
N
u
m
b
er
 o
f 
ce
lls
 ×
10
3 /
m
m
3
Exposure treatment group
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0-H 1-H 4-H 24-H
Trial 1
Trial 2
N
u
m
b
er
 o
f 
ce
lls
 ×
10
3 /
m
m
3
© Central University of Technology, Free State
C h a p t e r  5 :  L e u c o c y t e s   P a g e  | 76 
 
e. Eosinophil count  f. Basophil count 
      
Figure 5.4  Bar graphs of the comparison of Experimental Trial 1 and 2 mean values of  
  the different leucocyte parameter treatments. 
 
5.5 Discussion 
In contrast to human studies, several studies support the notion that ELF-EMF may influence 
leucocyte parameters. Similar to a number of previous studies in mice, this study showed an 
increase in the total leucocyte count after a short-term ELF-EMF exposure of one week, albeit not a 
significant increase. This increase was mainly represented by a non-significant increase in the 
number of lymphocytes. Other parameters that were affected by a one-week ELF-EMF exposure 
included a significant decrease in the number of neutrophils and basophils, while the number of 
eosinophils was significantly increased. In another study, exposure to ELF-EMF for one week also 
revealed an increase in the total leucocyte count in mice (de Kleijn et al. 2016). This increase was 
mainly represented by an increase in neutrophils, which was in contrast to what was found in this 
study. Similar to this study, Singh et al. (2012) also found that the number of leucocytes and 
lymphocytes was increased in mice exposed to ELF-EMF for six weeks, while the number of 
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outcome to these studies was the finding that no significant differences existed between control 
treatment groups and ELF-EMF exposure treatment groups for leucocyte parameters in mice after 
40 days of exposure (Cicekcibasi et al. 2008). Long-term exposure to ELF-EMF; 12 weeks in this 
study and 15 weeks in a study conducted by de Kleijn et al. (2016), did not reveal any significant 
differences between the control treatment groups and the ELF-EMF exposure groups within a 
particular leucocyte parameter. De Kleijn et al. (2016) suggested that mice undergoing a type of 
adaptation to ELF-EMF could explain the absence of differences between treatments, within a 
particular leucocyte parameter, in the long-term ELF-EMF exposure experiment. Bonhomme-Faivre 
et al. (1998a) suggested that this adaption to ELF-EMF could be attributed to a recovery of the 
haemopoetic system. 
In this study, immunological modifications were observed in leucocyte numbers in the 1-week 
experimental trial that were similar to those found by de Kleijn et al. (2016). De Kleijn et al. (2016) 
suggested that these changes may linked to stress-related parameters. In the short-term exposure 
ELF-EMF experiment conducted by de Kleijn et al. (2016) the stress-related parameter 
proopiomelanocortin (POMC) expression and plasma adrenocorticotropic hormone were significantly 
lower in the ELF-EMF exposed treatment group compared with unexposed control mice. De Kleijn et 
al. (2016) concluded that short-term ELF-EMF exposure may affect hypothalamic-pituitary-adrenal 
axis activation in mice and result in changes in stress hormone release, which in turn may explain 
changes in circulating leucocyte numbers and composition.  
Noteworthy outcomes of this study were the significant differences between most of the 1-week 
treatments and the 12-week treatments, including the control treatments. The exceptions were the 
number of neutrophils exposed for one hour and number of basophils exposed for four and 24 hours. 
Overall, the cell numbers were lower in the 12-week experimental trial when compared to the 1-week 
experimental trial, which supports the results obtained by de Kleijn et al. (2016), who attributed the 
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lower cell numbers to batch variation. Having found similar results to de Kleijn et al. (2016), it is 
unlikely that batch variation alone can be responsible for the lowered cell numbers in the 12-week 
experimental trial. In a similar experiment with rats, (Szemerszky et al. 2010) did find a significant 
proopiomelanocortin elevation and depressive-like behaviour following a 6-week continuous 
exposure to ELF-EMF exposure. Other contributing factors explaining the differences between the 
results of the control treatment groups of the short-term and long-term experiments could be 
attributed to subclinical stress caused by confinement (Moberg 2000; Dhabhar 2014), as well as the 
animal age difference at sacrifice (Çetin et al. 2006). The age of the animals at sacrifice of the short-
term experiment was 35 days, while the age of the animals of the long-term experiment was 112 
days. 
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Lymphocyte Cluster of Differentiation 
6.1 Introduction  
When cells differentiate, they undergo changes in gene expression. These changes are often 
expressed as changes in cell surface proteins. Many cell types express unique cell surface proteins. 
These proteins are used to characterise a cell’s specific origin, its state of differentiation and its state 
of activation (Delves et al. 2017).  
When investigating and identifying cell types; cell surface proteins are used as target molecules by 
applying the cluster of differentiation (CD) protocol. This protocol is applied particularly in 
immunophenotyping. In immunophenotyping these target cell surface proteins are referred to as CD 
markers and are used to associate cells with certain immune functions (Martini 2004). While the use 
of single CD markers to define cell populations is uncommon, the combination of CD markers allows 
for the identification of cell types with very specific definitions within the immune system. While only 
a fraction of the known CD markers has been thoroughly characterised, most of them have an 
important function, for example, CD4 and CD8 are critical in antigen recognition (Delves et al. 2017). 
Blood cells are divided into three lineages, of which the lymphocyte lineage forms the foundation of 
the adaptive immune system. The lymphocyte lineage of white blood cells is formed in the bone 
marrow and comprise of T-lymphocytes and B-lymphocytes (Figure 6.1). T-lymphocytes undergo 
maturation in the thymus, while B-lymphocytes leave the bone marrow and migrate to peripheral 
lymphoid tissues, such as lymph nodes (Marieb and Hoehn 2016). T-lymphocytes play a central role 
in cell-mediated immunity, while B-lymphocytes function in the humoral immunity system of the 
adaptive immune system. Helper T-lymphocytes are required for almost all adaptive immune 
responses and are responsible for the activation of other cells such as B-lymphocytes and 
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macrophages. They facilitate B-lymphocytes to secrete antibodies and macrophages to destroy 
ingested microorganisms, but they also facilitate the activation of cytotoxic T-lymphocytes to destroy 
infected target cells (Martini 2004). Cytotoxic T-lymphocytes destroy certain cell types, including 
foreign cells, cancer cells, and virus infected cells. 
 
 
Figure 6.1 T- and B-Lymphocyte CD lineages. 
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The helper and cytotoxic T-lymphocyte populations are identified by using two CD markers in 
combination. The CD3 marker, which occurs on a number of different cell types, is used in 
combination with the CD4 marker to identify the helper T-lymphocyte population, and in combination 
with CD8 to identify the cytotoxic T-lymphocyte population. CD3 is a multimeric protein complex 
composed of four distinct polypeptide chains; epsilon (ε), gamma (γ), delta (δ) and zeta (ζ), that 
assemble and function as three pairs of dimers (εγ, εδ, ζζ) (Chetty and Gatter 1994; Kjer-Nielsen et 
al. 2004). The CD4 marker is a monomeric type I transmembrane glycoprotein, while the CD8 
marker is a heterodimeric type I transmembrane glycoprotein comprising of an alpha (α) and a beta 
(β) polypeptide chain (Li et al. 2013). For the B-lymphocyte population, CD19 is a hallmark marker, 
which is a type I transmembrane glycoprotein (Wang et al. 2012). 
 
There is a paucity of studies investigating the effects of ELF-EMF on lymphocyte cell populations 
using CD markers in animals. De Kleijn et al. (2016) demonstrated an increase in CD4 lymphocytes 
in mice exposed to ELF-EMF continuously for seven days. In contrast, Bonhomme-Faivre et al. 
(2003) found that the CD4 lymphocyte population decreased significantly in mice after continuous 
exposure to ELF-EMF in a long-term experiment of 109 days. In this experiment the total lymphocyte 
population, as well as the natural killer lymphocyte population, were also significantly lower when 
compared to the control treatment group. Hashish et al. (2008) also demonstrated decreased 
numbers of T- and B-lymphocytes in mice exposed continuously to ELF-EMF for 30 days. 
The effects of ELF-EMF were studied on four CD markers in mice exposed for one week 
(Experimental Trial 1) and for twelve weeks (Experimental Trial 2). Three CD markers were used to 
enumerate three T-lymphocyte subpopulations. CD3 was used to identify the T-lymphocytes, CD4 
the helper T-lymphocytes and CD8 the cytotoxic T-lymphocytes. CD19 was used to identify the B-
lymphocyte population.  
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6.2 Experimental Trial 1: One-week exposure 
Overall, a few distinguishing patterns emerged for the four treatment groups of the different CD 
parameters. The ranges of the mean percentages were, for the most, similar for each of the 
treatment groups within the respective CD parameters (Table 6.1). The exceptions were the ranges 
of the mean percentages of the 24-hour treatment groups of CD3, CD4 and CD8 parameters. These 
treatment groups displayed relatively narrow ranges compared to the other treatment groups; which 
could be attributed to the substantial drop in the maximum values of the mean percentages within 
these treatment groups. The mean percentages demonstrated a slight increase towards the higher 
ELF-EMF exposure times for all the CD parameters.  
 
Most of the mean percentages of CD3, CD4 and CD8 parameters fell within the range of the control 
treatment group; except for the maximum percentages of the 1-hour and 4-hour treatment groups 
that were greater than the maximum percentage of the control treatment group. Similarly, for the 
CD19 parameter, most of the mean percentages fell within the range of the control treatment group; 
except for the minimum percentages of the 1-hour and 24-hour treatment groups that fell below the 
minimum percentage of the control treatment group. 
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Table 6.1 Summary statistics of the CD parameters of Experimental Trial 1. 
 
Variable Treatment group Minimum Maximum Range Mean 
Standard 
deviation 
CD3 
0-H (control) 7.40 79.00 71.60 26.06 17.49 
1-H 12.10 84.00 71.90 42.13 17.91 
4-H 14.20 92.00 77.80 38.26 16.64 
24-H 14.30 55.50 41.20 34.68 9.11 
CD4 
0-H (control) 5.10 57.00 51.90 19.42 13.40 
1-H 8.50 63.00 54.50 31.40 13.20 
4-H 10.60 68.00 57.40 28.08 11.98 
24-H 11.50 44.80 33.30 26.78 6.98 
CD8 
0-H (control) 1.30 20.00 18.70 6.70 4.21 
1-H 5.00 41.00 36.00 12.50 7.44 
4-H 2.40 29.00 26.60 10.28 6.35 
24-H 1.70 13.90 12.20 8.55 3.04 
CD19 
0-H (control) 2.00 59.00 57.00 18.11 15.80 
1-H 1.80 49.00 47.20 21.57 15.05 
4-H 3.20 44.20 41.00 21.42 12.06 
24-H 1.10 43.80 42.70 23.23 11.86 
H = hour 
A bar graph was constructed of the mean percentages of all the treatments of the different CD 
parameters to provide a visual perspective of the percentages of the respective treatments within 
each parameter. For all the CD parameters, the ELF-EMF exposure treatment groups displayed 
percentages that were greater than that of the control treatment group (0-hour control treatment 
group) (Figure 6.2). However, the mean percentages of the different treatment groups of parameter 
CD19 were, overall, rather similar. For all four CD parameters, the 1-hour treatment group 
demonstrated the highest mean percentages. 
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Figure 6.2 Bar graph showing the mean percentages of the different CD parameter 
treatments for Experimental Trial 1. 
 
ANOVA tests were performed to ascertain if significant differences existed between the different 
treatment groups within the different CD parameters. Highly significant differences were identified for 
the three parameters CD3, CD4 and CD8 at α = 0.05 (Table 6.2). The ANOVA test performed on the 
treatment groups of CD19 parameter did not reveal significant differences. 
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Table 6.2 ANOVA tests performed on the CD parameters of Experimental Trial 1. 
Parameter Source 
Sum of 
squares 
Degrees of 
freedom 
Mean 
square 
F P-value 
CD3 
Between groups 3,529.97 3.00 1,176.66 5.01 < 0.001 
Within groups 16,917.62 72.00 234.97   
Total 27,206.48 99.00    
CD4 
Between groups 1,920.46 3.00 640.15 5.00 < 0.001 
Within groups 9,210.66 72.00 127.93   
Total 15,024.82 99.00    
CD8 
Between groups 452.25 3.00 150.75 4.89 < 0.001 
Within groups 2,221.91 72.00 30.86   
Total 3,397.29 99.00    
CD19 
Between groups 345.70 3.00 115.23 0.68 0.57 
Within groups 12,272.28 72.00 170.45   
Total 18,649.55 99.00    
H = hour 
Tukey HSD tests were performed on CD3, CD4 and CD8 parameters to determine which of the 
different treatment groups differed from one another at α = 0.05. The Tukey HSD tests revealed that 
the 1-hour and 4-hour treatment groups differed from the control treatment group for CD3 and CD4 
parameters (Table 6.3). For CD8 parameter only the 1-hour treatment group differed from the control 
treatment group. 
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Table 6.3 Results of Tukey HSD tests for CD3, CD4 and CD8. 
CD3  CD4  CD8 
TG 0-H 1-H 4-H 24-H  TG 0-H 1-H 4-H 24-H  TG 0-H 1-H 4-H 24-H 
0-H      0-H      0-H     
1-H S     1-H S     1-H S    
4-H S NS    4-H S NS    4-H NS NS   
24-H NS NS NS   24-H NS NS NS   24-H NS NS NS  
S = significant; NS = non-significant; TG = treatment group; 0-H = control, 1-H = 1 hour, 4-H = 4 hours, 24-H = 24 hours 
6.3 Experimental Trial 2: Twelve-week exposure 
Overall, a few distinguishing patterns emerged that were clearly different when compared to 
Experimental Trial 1 for the four treatment groups of the different CD parameters. The ranges of the 
mean percentages were for all the treatment groups within the respective CD parameters smaller 
than those of Experimental Trial 1 (Table 6.4). The smaller ranges of the mean percentages were 
reflected by their increased minimum values and their decreased maximum values. The mean 
percentages recorded for CD3, CD4 and CD8 were greater than those recorded in Experimental 
Trial 1 for the control treatment groups, the 4-hour and the 24-hour treatment groups. The mean 
percentages of the 1-hour treatment group of these CD parameters were less that those recorded for 
Experimental Trial 1. In contrast, the mean percentages of all the treatment groups of CD19 were 
less than those recorded for Experimental Trial 1. 
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Table 6.4 Summary statistics of cluster of CD of Experimental Trial 2. 
Variable Treatment group Minimum Maximum Range Mean 
Standard 
deviation 
CD3 
0-H (control) 14.09 58.88 44.79 39.47 15.79 
1-H 15.09 69.96 54.87 39.27 13.62 
4-H 17.06 71.45 54.39 47.13 15.02 
24-H 13.66 70.71 57.05 43.83 15.99 
CD4 
0-H (control) 9.78 47.32 37.54 29.89 12.53 
1-H 9.70 54.05 44.35 29.27 11.12 
4-H 13.09 53.85 40.76 36.06 12.43 
24-H 6.36 52.65 46.29 33.50 13.07 
CD8 
0-H (control) 3.98 18.28 14.30 10.57 3.65 
1-H 3.79 18.47 14.68 11.04 3.39 
4-H 4.26 20.83 16.57 12.24 4.59 
24-H 4.96 26.00 21.04 12.21 4.65 
CD19 
0-H (control) 0.66 32.43 31.77 14.54 9.99 
1-H 1.38 30.00 28.62 12.07 6.27 
4-H 4.07 25.20 21.13 15.00 5.35 
24-H 3.25 37.12 33.87 16.99 9.26 
 H = hour 
A bar graph showing the mean percentages of all the treatments of the different CD parameters 
provides a visual perspective of the percentages of the respective treatments within each parameter. 
For the three CD parameters, CD3, CD4 and CD8, the 4-hour treatment groups demonstrated the 
highest mean percentages. This was in contrast to what was found for Experimental Trial 1, where 
the highest values were found for the 1-hour treatment group (Figure 6.3). The highest mean 
percentage for CD19 was recorded for the 24-hour treatment group. 
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Figure 6.3 Bar graph showing the mean percentages of the different CD parameter 
treatments for Experimental Trial 2. 
 
ANOVA tests were performed to ascertain if significant differences existed between the different 
treatment groups within the different CD parameters. No significant differences were found for all the 
CD parameters at α = 0.05 (Table 6.5). 
Table 6.5 ANOVA tests performed on the CD parameters of Experimental Trial 2. 
Parameter Source 
Sum of 
squares 
Degrees of 
freedom 
Mean square F P-value 
CD3 
Between groups 951.22 3.00 317.07 1.40 0.25 
Within groups 19,768.25 87.00 227.22   
Total 20,719.46 90.00    
CD4 
Between groups 702.64 3.00 234.21 1.55 0.21 
Within groups 13,141.35 87.00 151.05   
Total 13,843.98 90.00    
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Parameter Source 
Sum of 
squares 
Degrees of 
freedom 
Mean square F P-value 
CD8 
Between groups 44.84 3.00 14.95 0.87 0.46 
Within groups 1,491.93 87.00 17.15   
Total 1,536.78 90.00    
CD19 
Between groups 3.6.78 3.00 102.26 1.69 0.18 
Within groups 5,257.86 87.00 60.44   
Total 5,564.64 90.00    
H = hour 
6.4 Comparison of Experimental Trial 1 and Experimental Trial 2 
When the ranges of the mean percentages of the respective treatment groups of the different CD 
parameters of the two experimental trials were compared, some distinguishing patterns could be 
identified. The ranges were, for the most, larger for Experimental Trial 1 than for Experimental Trial 2 
(Table 6.6). The exceptions were the 24-hour treatment groups of CD3, CD4 and CD8, which 
displayed relatively narrow ranges of the mean percentages. It was difficult to identify distinguishing 
patterns when comparing the mean percentages of the treatment groups of the respective CD 
parameters. However, it was noted that for CD3, CD4 and CD8, the differences in the mean 
percentages of Experimental Trial 1 were greater for the 1-hour treatment groups when the two trials 
were compared, while the mean percentages of the other treatment groups of Experimental Trial 1 
were all smaller than those of Experimental Trial 2. For the other treatment groups of CD3, CD4 and 
CD8, the mean percentages of Experimental Trial 2 were all greater than Experimental Trial 1. For 
CD19, all the mean percentages of Experimental Trial 1 were greater than Experimental Trial 2. 
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Table 6.6 Comparison of ranges and means between Experimental Trials 1 and 2. 
Variable Treatment group 
Range 
1-week 
Mean 
1-week 
Range 
12-week 
Mean 
12-week 
Difference 
in ranges 
Difference 
in means 
CD3 
 
0-H (control) 71.60 26.06 44.79 39.47 26.81 -13.41 
1-H 71.90 42.13 54.87 39.27 17.03 2.86 
4-H 77.80 38.26 54.39 47.13 23.41 -8.87 
24-H 41.20 34.68 57.05 43.83 -15.85 -9.15 
CD4 
 
0-H (control) 5.90 19.42 37.54 29.89 -31.64 -10.47 
1-H 54.50 31.40 44.35 29.27 10.15 2.13 
4-H 57.40 28.08 40.76 36.06 16.64 -7.98 
24-H 33.30 26.78 46.29 33.50 -12.99 -6.72 
CD8 
 
0-H (control) 18.70 6.70 14.30 10.57 4.40 -3.87 
1-H 36.00 12.50 14.68 11.04 21.32 1.46 
4-H 26.60 10.28 16.57 12.24 10.03 -1.96 
24-H 12.20 8.55 21.04 12.21 -8.84 -3.66 
CD19 
0-H (control) 57.00 18.11 31.77 14.54 25.23 3.57 
1-H 47.20 21.57 28.62 12.07 18.58 9.50 
4-H 41.00 21.42 21.13 15.00 19.87 6.42 
24-H 42.70 23.23 33.87 16.99 8.83 6.24 
H = hour 
 
T-tests were performed to ascertain if the respective treatment groups of a CD parameter of 
Experimental Trial 1 differed significantly from the equivalent treatment group in Experimental Trial 
2. The t-tests revealed that 63% of the comparisons demonstrated significant or highly significant 
differences at α = 0.05 (Table 6.7). Two distinguishing patterns were noted. For CD3, CD4 and CD8, 
all the control treatment groups demonstrated significant differences between the two trials. For the 
24-hour treatment groups, the t-tests revealed significant differences for all the CD parameters. 
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Table 6.7 T-tests comparing the CD parameters of Experimental Trials 1 and 2. 
 
 
 
 
 
 
 
 
 
 
A visual perspective of the mean percentages of the respective exposure treatment groups of the 
two experimental trials shows the major differences. For the CD parameters CD3, CD4 and CD8, 
three of the treatments groups demonstrated higher mean percentages in Trial 2 than Experimental 
Trial 1 (Figure 6.3). For CD19 all the mean percentages of Experimental Trial 1 were greater than 
those of Experimental Trial 2.  
 
 
Parameter 
Treatment 
group 
df t P-value 
CD3 
 
0-H  37 -2.58 0.01 
1-H 45 0.64 0.53 
4-H 47 -1.94 0.05 
24-H 38 -2.49 0.02 
CD4 
 
0-H  36 -2.58 0.01 
1-H 47 0.62 0.54 
4-H 47 -2.28 0.03 
24-H 37 -2.27 0.03 
CD8 
 
0-H  38 -3.12    < 0.001 
1-H 32 0.90 0.37 
4-H 44 -1.23 0.22 
24-H 31 4.32 < 0.001 
CD19 
0-H  40 0.89 0.38 
1-H 32 2.91 < 0.001 
4-H 33 2.44 0.02 
24-H 45 2.01 0.04 
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a. CD3     b    CD4 
 
       
c. CD8 d. CD19 
   
Figure 6.4  Bar graph of the comparison of Experimental Trial 1 and 2 mean percentages 
  of the different  CD parameter treatments. 
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6.5 Discussion 
The lymphocyte subsets as identified by the four CD parameters CD3, CD4, CD8 and CD19 
demonstrated interesting differences between the T-lymphocyte populations and the B-lymphocyte 
populations. Mice that were ELF-EMF exposed for one hour in the one-week experimental trial 
demonstrated a substantial increase in the T-lymphocyte parameters CD3, CD4 and CD8, when 
compared to the other exposure treatment groups. Although T-lymphocyte subsets were greater 
than the control treatment groups in the longer exposure treatment groups, they were less than the 
1-hour treatment groups, with the 24-hour treatment groups approaching the values of the control 
treatment groups. De Kleijn et al. (2016) also found in a one-week exposure trial that CD3 and CD4 
lymphocyte subsets were significantly greater than the control treatment groups. In contrast, in the 
12-week trial of this study, the T-lymphocyte parameters CD3, CD4 and CD8 were substantially 
increased for all the exposure treatment groups, except for the 1-hour treatment groups. In a similar 
trial of 15 weeks, de Kleijn et al. (2016) found contrasting results, where no significant differences 
could be established for all the treatment groups of the CD3 and CD4 lymphocyte subsets. In a 
study conducted by Bonhomme-Faivre et al. (2003), the CD4 lymphocyte subset was substantially 
lower than the control group after 109 days of continuous exposure to ELF-EMF. 
The numeration of the CD19 B-lymphocyte subpopulations revealed conflicting patterns to what was 
found for the T-lymphocyte populations. In the one-week experimental trial, the CD19 lymphocytes 
were increased in all ELF-EMF exposure treatment groups. When the 12-week experimental trial 
was considered, all the treatment groups were substantially lower when compared to the one-week 
experimental trial. However, only the one-hour treatment group showed values that were less than 
the control treatment group. It appeared as if Bonhomme-Faivre et al. (2003) found similar outcomes 
for the CD19 lymphocyte subset. The CD19 lymphocytes of the ELF-EMF exposure treatment 
groups in the one-week experimental trials were all increased. Similarly, to the results of this study 
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de Kleijn et al. (2016) also found that the numbers of CD19 lymphocytes of all treatment groups 
were less in the 15-week trial when compared to the one-week trial. However, in contrast to this 
study, the one-hour treatment group in the 15-week trial demonstrated greater numbers that the 
control group. In a medium-term continuous exposure experiment, Hashish et al. (2008) identified 
decreased levels of B-lymphocytes in ELF-EMF exposed mice.  
This study suggests that the cell-mediated immune system, as well as the humoral immune system 
is affected differently when mice are exposed to ELF-EMF. In the short-term, mild exposure to ELF-
EMF (one hour per day for one week) may lead to the stimulation of the cell-mediated immune 
system. In contrast, when mice are exposed to ELF-EMF for a relatively long period, the cell-
mediated immune system appears to be stimulated by all periods of ELF-EMF exposure. The B-
lymphocytes of the humoral immune system, on the other hand, are stimulated in mice by any ELF-
EMF exposure in the short-term. In the long-term, all mice, whether exposed to ELF-EMF or not, 
respond with lowered B-lymphocyte populations, thereby compromising their adaptive immune 
system. 
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Discussion and Conclusions 
7.1 Introduction  
Human exposure to extremely low frequency electromagnetic fields (ELF-EMF) is part of modern 
life. These electromagnetic fields are generally frequencies < 300 Hz (Otto and von Mühlendahl 
2007; Ortega-Garcia et al. 2009; Redlarski et al. 2015; Zhang et al. 2016). During the 20th century, 
modern life has resulted in a steadily increasing exposure to ELF-EMF caused by devises that are 
human-made (D’Angelo et al. 2015).  
Both at home and at work, humans are exposed to a complex mixture of ELF-EMF, arising from 
artificial sources generating and transmitting electricity. These sources include domestic appliances, 
industrial equipment, telecommunications and broadcasting. The introduction of residential and 
industrial use of electricity for power, heating, and lighting, has brought about far greater and 
increasing exposures over the last 120 years (Ahlbom et al. 2001). 
The ever-increasing environmental exposure to ELF-EMF is of concern, mainly because of the 
potential for these electromagnetic fields to cause adverse health effects. Biological effects of ELF-
EMF exposures have been noted frequently (Bräscher et al. 2017), although the implication for 
specific health effects is not that clear (Simkó and Mattsson 2004). Several epidemiological studies 
have shown a possible association between human ELF-EMF exposure and increased incidence of 
childhood leukaemia, brain tumours or neurodegenerative diseases, breast cancer, and 
cardiovascular disease (Bouwens et al. 2001; D’Angelo et al. 2015). However, some studies have 
produced contrasting and beneficial results; for example, accelerated wound (Callaghan et al. 2008; 
Goudarzi et al. 2010) and bone healing (Bassett 1965; 1967; Dimitriou and Babis 2007; Pall 2013), 
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as well as an enhanced response of macrophages to bacterial challenges in humans (Akan et al. 
2010). In coccidian-infected chickens, a decreased severity of intestinal lesions was also observed 
(Elmusharaf et al. 2007). 
The basic interaction mechanism(s) between ELF-EMF exposure and living matter is still largely 
unknown. Hypotheses have been suggested, although none is convincingly supported by 
experimental data (Simkó and Mattsson 2004). Various cellular components, processes, and 
systems can be affected by ELF-EMF exposure, therefore it has been suggested that ELF-EMF 
exposure results in signal transduction pathways and modulation of oxygen radicals (Liburdy et al. 
1993; Rollwitz et al. 2004; Simkó and Mattsson 2004; Markov 2007; Frahm et al. 2010). Cuppen et 
al. (2007) also suggested that ELF-EMF exposure causes stress at the cellular level and that this 
leads to the production of cytokines and consequently several biological responses, including 
immune responses. A similar hypothesis, put forward by de Kleijn et al. (2016), suggested that ELF-
EMF exposure may affect stress regulation and, as a result, will affect number and activation of 
leukocytes. 
Animal models are extensively used to provide insight into the mechanisms underlying many human 
diseases. Although larger species, such as dogs, pigs and non-human primates, are more closely 
related to humans than mice; working with these large animals is extremely expensive and is fraught 
with ethical concerns. Thus, mouse models are still used extensively as a means to elucidate 
mechanisms of human pathology (Justice and Dhillon 2016). This study was thus undertaken to 
elucidate the effects of ELF-EMF on red blood cells, thrombocytes, white blood cells and lymphocyte 
cluster of differentiation markers in the BALB/c N1H mouse strain. 
 
© Central University of Technology, Free State
C h a p t e r  7 :  D i s c u s s i o n  a n d  C o n c l u s i o n  P a g e  | 97 
 
7.2 Effects of ELF-EMF exposure  
Contrary to the expectation for this project, not all blood parameters were affected by  short-term 
ELF-EMF exposure. In the short-term exposure experiment, a few noteworthy outcomes could be 
identified. ELF-EMF did not have a significant (p > 0.05) effect on the erythrocyte population and the 
related parameters haemoglobin concentration and haematocrit. A similar outcome was 
demonstrated by the thrombocyte population. Similarly, the overall leucocyte population also was not 
affected by ELF-EMF exposure. However, when investigating the different leucocyte cell types, 
significant changes were noted in the number of granulocytes (p < 0.0001), whereas the 
agranulocytes did not reveal any significant differences in number (p > 0.05). The number of 
eosinophils and basophils was elevated, while the number of neutrophils was suppressed. The T-
lymphocyte cluster of differentiation subtypes, CD3, CD4 and CD8 populations demonstrated 
significant increases in number, particularly in the one-hour per day ELF-EMF exposure group (p < 
0.001). The B-lymphocyte cluster of differentiation subtype CD19, did not show any differences 
when compared to the control group (p = 0.57). 
Similarly, to the short-term exposure experiment, not all blood parameters were affected by long-
term ELF-EMF exposure. When considering the long-term exposure experiment an unexpected 
outcome was encountered for the control treatment groups. The control groups were, for the most, 
highly significantly different when compared to the short-term exposure experiment (p < 0.001). In 
this study, the control groups showed suppressed numbers of total leucocytes, lymphocytes, 
monocytes, neutrophils and basophils, while the eosinophils were significantly elevated when 
compared to the short-term experiment control groups. The control groups of the T-lymphocyte 
cluster of differentiation subtypes, CD3, CD4 and CD8 populations, were also elevated when 
compared to the short-term experiment. These data indicated that long-term confinement resulted in 
other physiological changes, irrespective whether the animals were exposed to ELF-EMF or not. 
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Because the animals in this study were considered to be specifically pathogen free and because 
exposure to microbes during the experiments was limited and equal in all treatment groups, it was 
concluded that illness due to exposure to pathogens could not be responsible for the difference. 
Confinement, by its nature, restricts behavioural options for the animals and it is also known that 
animals confined in cages for a lengthy period are more vulnerable to subtle effects of subclinical 
stress, which could have contributed to these results (Moberg 2000; Dhabhar 2014). Studies in rats 
indicated that ELF-EMF exposure enhanced the anxiety-like behaviour in the confined animals 
(Szemerszky et al. 2010). A further contributing factor to the difference in the results of the control 
groups of the short-term and long-term experiments could be attributed to the difference in age of 
the animals (Çetin et al. 2006); 35 days old in the short-term and 112 days in the long-term 
experiment. 
When considering the effect of ELF-EMF in the long-term experiment, no significant differences 
could be established between the control treatment groups and the exposure treatment groups for all 
the parameters. De Kleijn et al. (2016) attributed these equivalent numbers to be as a result of long-
term exposed mice undergoing adaptation to ELF-EMF. Bonhomme-Faivre and colleagues (1998a) 
also showed that mice exposed to ELF-EMF demonstrated recovery of the haemopoetic system 
even after 350 days of exposure. Although the control treatment group and exposure treatment 
groups of the different parameters did not differ from one another, it was noticeable that the four-
hour per day ELF-EMF exposure resulted in an elevation of the number of red blood cells, 
haemoglobin concentration and haematocrit. Similarly, the basophils were also elevated in the one-
hour per day ELF-EMF exposure group. 
The debate continues about the consequences of ELF-EMF exposure to human health. Little 
evidence exists that ELF-EMF exposure affects blood cell parameters (Selmaoui et al. 1996; 
Bonhomme-Faivre, et al. 1998b; Dasdag et al. 2002; Ichinose et al. 2004; Touitou et al. 2013). A 
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number of epidemiologic studies appear to support the hypothesis that prolonged exposure to ELF-
EMF may be associated with increased risk of childhood cancer, particularly lymphatic leukaemia, 
lymphomas, and brain tumours (Dasdag et al. 2002). In contrast, the results of this study support the 
notion that ELF-EMF exposure, in the short-term, could cause haematological (de Kleijn et al. 2016) 
and immunological modifications, albeit in mice. In the long-term, ELF-EMF exposure in mice 
remains difficult to interpret, however, indications suggest that recovery from the effects of ELF-EMF 
is possible. 
7.3 Concluding remarks 
The unexpected results of this study revealed that many gaps still exist in the understanding of the 
underlying effects of ELF-EMF exposure on living tissue, particularly blood parameters. In mice the 
activation of the immune response could be studied on bacterially infected animals. The role of ELF-
EMF exposure on reactive oxygen species and cellular inflammation remain important questions to 
be answered. Another important aspect that requires investigation is the role of confinement of 
animals on the results of experiments. Finally, how the effects of ELF-EMF exposure in mice relate 
to ELF-EMF exposure humans, require further elucidation. 
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